POPULARITY
354 episodes with Medicare
260 episodes with Medicare
277 episodes with Medicare
150 episodes with Medicare
205 episodes with Medicare
186 episodes with Medicare
100 episodes with Medicare
144 episodes with Medicare
126 episodes with Medicare
129 episodes with Medicare
135 episodes with Medicare
115 episodes with Medicare
87 episodes with Medicare
145 episodes with Medicare
75 episodes with Medicare
50 episodes with Medicare
127 episodes with Medicare
149 episodes with Medicare
121 episodes with Medicare
121 episodes with Medicare
60 episodes with Medicare
132 episodes with Medicare
104 episodes with Medicare
146 episodes with Medicare
37 episodes with Medicare
58 episodes with Medicare
41 episodes with Medicare
51 episodes with Medicare
19 episodes with Medicare
15 episodes with Medicare
70 episodes with Medicare
28 episodes with Medicare
36 episodes with Medicare
74 episodes with Medicare
40 episodes with Medicare
41 episodes with Medicare
26 episodes with Medicare
24 episodes with Medicare
30 episodes with Medicare
50 episodes with Medicare
48 episodes with Medicare
37 episodes with Medicare
65 episodes with Medicare
37 episodes with Medicare
62 episodes with Medicare
79 episodes with Medicare
26 episodes with Medicare
58 episodes with Medicare
31 episodes with Medicare
52 episodes with Medicare
29 episodes with Medicare
15 episodes with Medicare
53 episodes with Medicare
32 episodes with Medicare
20 episodes with Medicare
20 episodes with Medicare
27 episodes with Medicare
32 episodes with Medicare
32 episodes with Medicare
20 episodes with Medicare
22 episodes with Medicare
24 episodes with Medicare
35 episodes with Medicare
49 episodes with Medicare
12 episodes with Medicare
16 episodes with Medicare
45 episodes with Medicare
19 episodes with Medicare
25 episodes with Medicare
17 episodes with Medicare
10 episodes with Medicare
52 episodes with Medicare
15 episodes with Medicare
39 episodes with Medicare
12 episodes with Medicare
14 episodes with Medicare
24 episodes with Medicare
19 episodes with Medicare
14 episodes with Medicare
15 episodes with Medicare
19 episodes with Medicare
22 episodes with Medicare
33 episodes with Medicare
14 episodes with Medicare
18 episodes with Medicare
15 episodes with Medicare
15 episodes with Medicare
31 episodes with Medicare
16 episodes with Medicare
24 episodes with Medicare
11 episodes with Medicare
12 episodes with Medicare
16 episodes with Medicare
20 episodes with Medicare
14 episodes with Medicare
15 episodes with Medicare
15 episodes with Medicare
16 episodes with Medicare
15 episodes with Medicare
28 episodes with Medicare
17 episodes with Medicare
8 episodes with Medicare
8 episodes with Medicare
16 episodes with Medicare
7 episodes with Medicare
26 episodes with Medicare
26 episodes with Medicare
35 episodes with Medicare
19 episodes with Medicare
261 episodes with Medicare
10 episodes with Medicare
6 episodes with Medicare
19 episodes with Medicare
10 episodes with Medicare
13 episodes with Medicare
12 episodes with Medicare
12 episodes with Medicare
7 episodes with Medicare
14 episodes with Medicare
15 episodes with Medicare
12 episodes with Medicare
14 episodes with Medicare
13 episodes with Medicare
11 episodes with Medicare
10 episodes with Medicare
6 episodes with Medicare
21 episodes with Medicare
15 episodes with Medicare
13 episodes with Medicare
18 episodes with Medicare
13 episodes with Medicare
10 episodes with Medicare
7 episodes with Medicare
17 episodes with Medicare
11 episodes with Medicare
21 episodes with Medicare
13 episodes with Medicare
212 episodes with Medicare
12 episodes with Medicare
6 episodes with Medicare
10 episodes with Medicare
13 episodes with Medicare
10 episodes with Medicare
7 episodes with Medicare
13 episodes with Medicare
12 episodes with Medicare
6 episodes with Medicare
10 episodes with Medicare
10 episodes with Medicare
7 episodes with Medicare
189 episodes with Medicare
11 episodes with Medicare
11 episodes with Medicare
188 episodes with Medicare
9 episodes with Medicare
8 episodes with Medicare
9 episodes with Medicare
18 episodes with Medicare
10 episodes with Medicare
5 episodes with Medicare
10 episodes with Medicare
9 episodes with Medicare
8 episodes with Medicare
8 episodes with Medicare
6 episodes with Medicare
18 episodes with Medicare
23 episodes with Medicare
9 episodes with Medicare
13 episodes with Medicare
9 episodes with Medicare
9 episodes with Medicare
8 episodes with Medicare
7 episodes with Medicare
9 episodes with Medicare
6 episodes with Medicare
9 episodes with Medicare
11 episodes with Medicare
5 episodes with Medicare
10 episodes with Medicare
11 episodes with Medicare
9 episodes with Medicare
10 episodes with Medicare
10 episodes with Medicare
9 episodes with Medicare
12 episodes with Medicare
8 episodes with Medicare
9 episodes with Medicare
8 episodes with Medicare
4 episodes with Medicare
6 episodes with Medicare
9 episodes with Medicare
10 episodes with Medicare
7 episodes with Medicare
8 episodes with Medicare
20 episodes with Medicare
153 episodes with Medicare
6 episodes with Medicare
8 episodes with Medicare
In this 2019 episode, when oncologist Soe Maunglay moves to Michigan, he's excited to join Farid Fata's practice. But Fata's controlling and odd ways make him question his decision to take the job. When Maunglay looks into a patient's records, he's shocked at what he finds: Fata is giving chemotherapy and other treatments to patients who don't need it, some of whom don't have cancer at all. His motive? Stealing money from Medicare.
On January 13, the Supreme Court stayed the Occupational Safety and Health Administration's (OSHA) COVID-19 vaccine-or-test mandate for large businesses, but allowed a vaccine mandate for staff at facilities receiving Medicare and Medicaid funding to go into effect. An expert panel joined us to break down these rulings' implications for administrative law, with a particular focus on what they might mean for the future of the non-delegation and major questions doctrines.Featuring:- Karen Harned, Executive Director, National Federation of Independent Business Small Business Legal Center- Ilan Wurman, Associate Professor of Law, Sandra Day O'Connor College of Law, Arizona State University- [Moderator] Luke A. Wake, Attorney, Pacific Legal FoundationVisit our website – www.RegProject.org – to learn more, view all of our content, and connect with us on social media.
Last week, Medicare took an unprecedented step to restrict patients' access to the first new Alzheimer's disease treatment in nearly 20 years. We talk with a doctor, a patient and a former federal official about this unusual move and its wide-ranging implications.Guests:Jay Reinstein, Alzheimer's disease patient and advocateSharon Sha, MD, MS, Clinical Associate Professor of Neurology and Neurological Sciences, Stanford UniversitySean Tunis, MD, MSc, Senior Fellow, Tufts Center for Evaluation of Value and Risk in Health, former FDA advisor and former CMS officialRead a full transcript and dig deeper into the issues explored in today's episode on our website.Support this type of journalism today by making a donation.Sign up for our weekly newsletter to see what research health policy experts are reading right now, plus recommendations from our staff.Follow us on Twitter. See acast.com/privacy for privacy and opt-out information.
: Approximately 800,000 people in the US have a heart attack every year? 1 in 4 people have had previously had a heart attack. When an individual is recovering from a heart attack or has a serious heart problem, Cardiac rehabilitation can be an instrumental part of not only the individual's recovery, but also in preventing future heart attacks. Today we are going to hear from Ade Adesanya, Co-founder and President of Moving Analytics, a company that offers Cardiac Rehabilitation in the comfort of the patient's home. We'll learn exactly what Cardiac Rehabilitation entails, and why many people fail to participate despite the demonstrated success of these programs. Show notes: Favorite Book: Crossing The Chasm by Geoffrey Moore. Podcasts: Tim Ferris Podcast; Access & Opportunity with Carla Harris.
In the first conversation of the year Gist Healthcare co-founders, Chas Roades and Lisa Bielamowicz discuss the healthcare trends they're watching for 2022, including the next phase of the COVID pandemic, the challenge of rising labor costs, surging investment in digital health, and the shifting demographics of Medicare.
Advance care planning is a term used to describe when a person prepares for future management of serious or terminal illness, including developing an advance care directive or what is sometimes is called a living will.Beginning in January of 2016, Medicare made it possible for certain clinicians to bill for their work for patients to develop advance care plans.Despite the new billing option, uptake has been quite slow.In health care, we often use financial incentives to motivate behavior change. You might have expected that simply creating a payment option for advance care planning would make it happen.Keren Ladin from Tufts University joins Health Affairs Editor-in-Chief Alan Weil on A Health Podyssey to discuss the reasons Medicare's payment policy has not led to the greater pursuit of advance care planning.Ladin and coauthors published a paper in the January 2022 issue of Health Affairs examining the limited use of advance care planning billing codes among clinicians. Their qualitative study revealed a number of potential explanations for low use that can help us understand why a seemingly simple payment change doesn't automatically yield a desired result.Barriers to use of the advance care planning billing codes include institutional practices, concerns about the effects on patients and more.If you enjoy this interview, order the January 2022 Health Affairs issue.Pre-order the February 2022 Racism and Health issue.Subscribe: RSS | Apple Podcasts | Spotify | Stitcher | Google Podcasts
Jason, Pascal, Kuba, and Djene discuss some of the top news stories of the week: the death of Sidney Poitier, the protests in Kazakhstan, and the new push for Medicare in California. About TIR Thank you, guys, again for taking the time to check this out. We appreciate each and every one of you. If you have the means, and you feel so inclined, BECOME A PATRON! We're creating patron-only programming, you'll get bonus content from many of the episodes, and you get MERCH! Become a patron now: https://www.patreon.com/join/BitterLakePresents Please also like, subscribe, and follow us on these platforms as well, especially YouTube! THANKS Y'ALL YouTube: www.youtube.com/thisisrevolutionpodcast Twitch: www.twitch.tv/thisisrevolutionpodcast & www.twitch.tv/leftflankvets Facebook: https://www.facebook.com/Thisisrevolutionpodcast/ Twitter: @TIRShowOakland Instagram: @thisisrevolutionoakland Pascal Robert in Black Agenda Report: https://www.blackagendareport.com/author/PascalRobert Get THIS IS REVOLUTION Merch here: www.thisisrevolutionpodcast.com Get the music from the show here: https://bitterlakeoakland.bandcamp.com/ Follow Djene Bajalan @djenebajalan Follow Kuba Wrzesniewski @DrKuba2
The Supreme Court issued rulings on two critical cases involving the Biden Administration's vaccine mandates amid the COVID-19 pandemic. The justices said the Occupational Safety and Health Administration is not allowed to implement a rule requiring employers with more than 100 workers to have their workers either get vaccinated for the virus or test weekly and wear a mask in the office. In the other case, the court upheld a vaccine mandate imposed by the Department of Health and Human Services on health care facilities that receive funding from Medicare or Medicaid. We wanted to dig into these decisions on their merits, and look at what they mean for the future, so we caught up with Craig Green, Professor of Law at Temple University's Beasley School of Law. Learn more about your ad choices. Visit podcastchoices.com/adchoices
My guest today has over 10 years of global investing experience and is the founder of Boardwalk Wealth with over 1,100 units under management and over 2,000 units bought and sold. Omar Khan is responsible for capital raising, strategic planning, and investor relations while focusing on acquiring value-add multifamily and apartments across the southeast. Today, Omar is going to share his high-level perspective on the three phases of apartment investing: sourcing deals, asset management, and liquidation events. You'll learn how Omar talks the right "language" with brokers and uses specific phrasing to indicate that he's someone who can follow through on an acquisition. You'll also learn the systems he has in place to provide benchmarks and goals for his teams to add value to his investments. And you'll learn several key differentiators Omar uses when it comes to profiting from a cash-out refinance or sale. You're definitely going to benefit from the sophisticated strategies and processes Omar shares during today's conversation. You can find out more about Omar through email or his website: omar@boardwalkwealth.com www.boardwalkwealth.com Today's episode is brought to you by Green Property Management, now offering a $250 per unit project allowance to new clients in West Michigan. Text "Green250" to 21000, or visit them at https://www.livegreenlocal.com/. And RCB & Associates, helping Michigan-based real estate investors and small business owners navigate the complex world of health insurance and Medicare benefits. Visit https://www.rcbassociatesllc.com/ to learn more.
In our ongoing campaign against the corporate assault on America's healthcare system, Ralph welcomes Kip Sullivan of “Healthcare for All Minnesota” to talk about what he terms “the creeping privatization of Medicare,” and tells us the story of how that ongoing corporatization is based on one particularly destructive yet durable myth.
In the wake of two major vaccine-mandate decisions at the high court this week, Dahlia Lithwick is joined by Andy Slavitt, former senior adviser to Biden's White House pandemic response team. Slavitt was also the acting administrator of the Centers of Medicare and Medicaid Services from 2015 to 2017. He hosts the In the Bubble podcast, and is the author of Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response. In our Slate Plus segment, Dahlia is joined by Mark Joseph Stern for more analysis of the vaccine cases, plus a look at state efforts to bar participants in the Jan. 6 insurrection from office, several vitally important state Supreme ourt decisions and what they suggest, and the refusal of Neil Gorsuch to mask up at the high court. Sign up for Slate Plus now to listen and support our show. Podcast production by Sara Burningham. Learn more about your ad choices. Visit megaphone.fm/adchoices
In the wake of two major vaccine-mandate decisions at the high court this week, Dahlia Lithwick is joined by Andy Slavitt, former senior adviser to Biden's White House pandemic response team. Slavitt was also the acting administrator of the Centers of Medicare and Medicaid Services from 2015 to 2017. He hosts the In the Bubble podcast, and is the author of Preventable: The Inside Story of How Leadership Failures, Politics, and Selfishness Doomed the U.S. Coronavirus Response. In our Slate Plus segment, Dahlia is joined by Mark Joseph Stern for more analysis of the vaccine cases, plus a look at state efforts to bar participants in the Jan. 6 insurrection from office, several vitally important state Supreme ourt decisions and what they suggest, and the refusal of Neil Gorsuch to mask up at the high court. Sign up for Slate Plus now to listen and support our show. Podcast production by Sara Burningham. Learn more about your ad choices. Visit megaphone.fm/adchoices
States are like dominos. When one state enacts a health policy, others replicate. Oregon's Medicaid draft 1115 waiver has several red flags for patient healthcare access, and all patients should watch this carefully.Meghan Moyer, the public policy director at Disability Rights Oregon, explains why the waiver is a concern for chronic and rare disease patients. From discriminatory healthcare metrics that determine coverage to a closed formulary that would hinder access to FDA accelerated approval drugs, it's filled with problems for patients. Plus, get the latest news on Medicare. Terry and Dr. Bob explain what you need to know about a proposed CMS Rule that attempts to lower costs in Medicare Part D, plus the limited Medicare Part B coverage for Alzheimer's treatments. Hosts: Terry Wilcox, Executive Director, Patients RisingDr. Robert Goldberg, “Dr. Bob,” Co-Founder and Vice President of the Center for Medicine in the Public InterestKate Pecora, Field Correspondent, Patients RisingGuests:Meghan Moyer, Public Policy Director, Disability Rights OregonJim Sliney Jr., Director of Patient Outreach, Patients Rising Janet Roberts, Patient CorrespondentLinks:Patients Rising Now's Comments on Oregon's 1115 Waiver and Impact on AccessThe Rare Access Action Project's Comments on Oregon's Health Authority's Section 1115 Waiver CMS Takes Action to Lower Out of Pocket Medicare Part D Prescription Drug Costs Section 1115 State Waiver List - Medicaid Medicare limits Aduhelm Coverage Clinical Trials Bob Saget's remembered as a Scleroderma advocate " For Hope " Movie Produced by Bob Saget Patients Rising Advocacy Master Class ApplicationShare your healthcare story on the podcast!Need help?The successful patient is one who can get what they need when they need it. We all know insurance slows us down, so why not take matters into your own hands? Our Navigator is an online tool that allows you to search a massive network of health-related resources using your zip code so you get local results. Get proactive and become a more successful patient right now at PatientsRisingConcierge.orgHave a question or comment about the show, or want to suggest a show topic or share your story as a patient correspondent?Drop us a line: podcast@patientsrising.orgThe views and opinions expressed herein are those of the guest(s)/ author(s) and do not reflect the official policy or position of Patients Rising.
If you've done any work in the fields of Geriatrics Medicine or Healthy Aging, you've almost certainly come across Jennie Chin Hansen, my guest on today's episode. Jennie is the former President of AARP, the former CEO of the American Geriatrics Society and currently a Board Member of the SCAN Health Plan (which funds the Healthy Skeptic, MD Podcast). Jennie also spent 25 years as a nurse leader at the San Francisco-based On Lok program developing creative care models for older adults, including the Program for All-Inclusive Care for the Elderly (PACE), which has become a national Medicare program. In today's episode, Jennie and I discussed what the next several years may look like for the field of Geriatrics and the care of older adults.
The Supreme Court rules the vaccine requirement for healthcare workers can go forward in facilities that receive Medicare and Medicaid reimbursement. This Omicron wave is particularly hard for parents of kids 5 and under who can't get vaccinated. And primary care enablement company Aledade acquires advanced care planning company Irish Healthcare.
The various appeals over the OSHA Emergency Temporary Standard (ETS) and the Center for Medicare & Medicaid Services (CMS) health care worker vaccination mandate were argued before the U.S. Supreme Court this past Friday, January 7, 2022. Those who listened to the Court's livestream heard over three hours of intense, often frustrating and inaccurate arguments as to why the mandates should either be struck down or remain in effect. Today, Rick Green joins me to discuss. *** Turtle Twins | Find the show notes here --- This episode is sponsored by · Anchor: The easiest way to make a podcast. https://anchor.fm/app --- Send in a voice message: https://anchor.fm/heidistjohn/message Support this podcast: https://anchor.fm/heidistjohn/support
In this 2019 episode, a bustling oncology practice in Michigan is hiding something sinister. Patients come to Farid Fata at their most vulnerable, after they've been diagnosed with cancer or to receive the life-altering diagnosis. But when Angela, an oncology nurse, arrives at one of Fata's well-regarded clinics for an interview, she finds that nothing is as it seems. Horrified by what she sees, she reports the doctor for committing an unthinkable form of Medicare fraud.
Play during opening: 0:00-0:10 …and more on today's CrossPolitic Daily News Brief. This is Toby Sumpter. Today is Friday, January 14, 2022. SCOTUS Blocks Biden VAX Mandate & Upholds Healthcare Worker Mandate https://www.cnbc.com/2022/01/13/supreme-court-ruling-biden-covid-vaccine-mandates.html The Supreme Court on Thursday blocked the Biden administration from enforcing its sweeping vaccine-or-test requirements for large private companies, but allowed a vaccine mandate to stand for medical facilities that take Medicare or Medicaid payments. The rulings came three days after the Occupational Safety and Health Administration's emergency measure for businesses started to take effect. The mandate required that workers at businesses with 100 or more employees get vaccinated or submit a negative Covid test weekly to enter the workplace. It also required unvaccinated workers to wear masks indoors at work. “Although Congress has indisputably given OSHA the power to regulate occupational dangers, it has not given that agency the power to regulate public health more broadly,” the court wrote in an unsigned opinion. “Requiring the vaccination of 84 million Americans, selected simply because they work for employers with more than 100 employees, certainly falls in the latter category,” the court wrote. President Joe Biden, in a statement, said the Supreme Court chose to block requirements that are life-saving for workers. Biden called on states and businesses to step up and voluntarily institute vaccination requirements to protect workers, customers and the broader community. “The Court has ruled that my administration cannot use the authority granted to it by Congress to require this measure, but that does not stop me from using my voice as President to advocate for employers to do the right thing to protect Americans' health and economy,” Biden said. In a separate, simultaneously released ruling on the administration's vaccination rules for health-care workers, a 5-4 majority sided with the Biden administration. “We agree with the Government that the [Health and Human Services] Secretary's rule falls within the authorities that Congress has conferred upon him,” said the majority, writing that the rule “fits neatly within the language of the statute.” “After all, ensuring that providers take steps to avoid transmitting a dangerous virus to their patients is consistent with the fundamental principle of the medical profession: first, do no harm,” the majority opinion read. Justices Clarence Thomas, Samuel Alito, Neil Gorsuch and Amy Coney Barrett, four of the six conservatives on the nine-seat bench, dissented. Kavanaugh and Roberts joined the three liberals to enforce this ruling. “I do not think that the Federal Government is likely to be able to show that Congress has authorized the unprecedented step of compelling over 10,000,000 healthcare workers to be vaccinated on pain of being fired,” Alito wrote in his dissent. FDA Issues Racist Triage Rationing for COVID Treatments https://freebeacon.com/coronavirus/food-and-drug-administration-drives-racial-rationing-of-covid-drugs/ Fron the Washington Free Beacon: In New York, racial minorities are automatically eligible for scarce COVID-19 therapeutics, regardless of age or underlying conditions. In Utah, "Latinx ethnicity" counts for more points than "congestive heart failure" in a patient's "COVID-19 risk score"—the state's framework for allocating monoclonal antibodies. And in Minnesota, health officials have devised their own "ethical framework" that prioritizes black 18-year-olds over white 64-year-olds—even though the latter are at much higher risk of severe disease. These schemes have sparked widespread condemnation of the state governments implementing them. But the idea to use race to determine drug eligibility wasn't hatched in local health departments; it came directly from the federal Food and Drug Administration. When the FDA issued its emergency use authorizations for monoclonal antibodies and oral antivirals, it authorized them only for "high risk" patients—and issued guidance on what factors put patients at risk. One of those factors was race. The FDA "fact sheet" for Sotrovimab, the only monoclonal antibody effective against the Omicron variant, states that "race or ethnicity" can "place individual patients at high risk for progression to severe COVID-19." The fact sheet for Paxlovid, Pfizer's new antiviral pill, uses the Centers for Disease Control and Prevention's definition of "high risk," which states that "systemic health and social inequities" have put minorities "at increased risk of getting sick and dying from COVID-19." The guidance sheets are nonbinding and do not require clinicians to racially allocate the drugs. But states have nonetheless relied on them to justify race-based triage. "The FDA has acknowledged that in addition to certain underlying health conditions, race and ethnicity ‘may also place individual patients at high risk for progression to severe COVID-19,'" Minnesota's plan reads. "FDA's acknowledgment means that race and ethnicity alone, apart from other underlying health conditions, may be considered in determining eligibility for [monoclonal antibodies]." Utah's plan contains similar language. In a section on the "Ethical Justification for Using Race/Ethnicity in Patient Selection," it notes that the FDA "specifically states that race and ethnicity may be considered when identifying patients most likely to benefit from this lifesaving treatment." The FDA declined to comment on either state's plan, saying only that "there are no limitations on the authorizations that would restrict their use in individuals based on race." The triage plans are part of a broader push to rectify racial health disparities through race-conscious means. In March of last year, for example, two doctors at Brigham and Women's Hospital in Boston outlined an "antiracist agenda for medicine" that involved "offering preferential care based on race." And last year, Vermont and New Hampshire both gave racial minorities priority access to the COVID-19 vaccine, resulting in at least one formal civil rights complaint against New Hampshire. The trend has alarmed Roger Severino, the former civil rights director at the Department of Health and Human Services, who called racial preferences in medicine a "corrosive and grossly unfair" practice. "Our civil rights laws are not suspended during a public health emergency," Severino said. "We should never deny someone life-saving health care because of the color of their skin." The triage plans show how federal guidelines can encourage this sort of race discrimination. They also suggest that the FDA is making political judgments, not just scientific ones. "They're injecting politics into science," said a former senior HHS official. "That's something the Trump administration was pilloried for allegedly doing." One clear sign of that politicization, several legal and medical experts said, is the guidance's double standard between race and sex. Men in the United States have proven to be about 60 percent more likely than women to die of the disease, according to research from the Brookings Institution, and within some age brackets the mortality gap is even larger. But the FDA doesn't list sex as a risk factor anywhere in its guidance. And while the Utah scheme does take it into account, the New York and Minnesota schemes do not. Nor do they or the FDA give any weight to geography and socioeconomic status, both of which are associated with COVID-19 mortality. Instead, the triage plans give more weight to race than to many comorbidities. In Minnesota's scoring system, "BIPOC status" is worth two points, the same as diabetes and cardiovascular disease, whereas "hypertension in a patient 55 years and older" is worth just one. In Utah's scoring system, "Non-white race or Hispanic/Latinx ethnicity" is worth two points—the same amount as diabetes, obesity, and "severely immunocompromised"—while hypertension, congestive heart failure, chronic pulmonary disease, and "shortness of breath" count for one each. Men do receive one extra point under the Utah scheme, on the grounds that "male gender is associated with increased risk of severe COVID-19." Nonbinary patients, the document says, "may choose to answer" questions about their gender identity "with that background information." Speaking of Woke medicine… Microsoft WORD Will Now Offer Woke Corrections https://notthebee.com/article/microsoft-word-introduces-new-woke-feature-to-monitor-your-language?fbclid=IwAR0sxOqYrccyxxhgAfuKMSuVVCtBFRRQaHfC8qs1PZ3HmOtL4S6PU6Z8DAE From Not the Bee: Microsoft has just introduced a woke, politically correct feature that I don't think anyone ever asked for… Traditionally, Microsoft Word has been used by its 250 million users for things such as spelling, punctuation, and grammar checks. But that wasn't enough for the tech giant. They (probably) thought, "spelling and grammar checks are great and all but what we really want to do is influence and control the masses." Control is the biggest rave these days. Word will now highlight no-no words with a purple line beneath any problematic words or phrases that focus on gender, age, sexual orientation, ethnicity or even "socioeconomic status." Red lines are for spelling errors. Green lines for grammar mistakes. And now, purple lines are politically correct language police alerts. If you type a bigoted word like, let's say... "postman," Word will offer less offensive, gender-neutral alternatives like "mail carrier" or "postal worker." The software also suggests altering astronaut Neil Armstrong's famous quote from "one giant leap for mankind," to "humankind" or "humanity" instead. Who knew Neil Armstrong was such a sexist bigot... Microsoft Word knew. In the lyrics to Barry Manilow's party favourite Copacabana, Microsoft suggests Lola be referred to as a "dancer," "performer" or "performing artist" rather than a "showgirl." Word is not just policing your language (and by default, your thoughts) but it seems as though Microsoft wants us to re-write and re-imagine history by suggesting we change famous quotes. It also proposes changing "maid" to "house cleaner." Other changes include "headmaster" (Word suggests "principal"), "mistress" ("lover"), "master" ("expert"), "manpower" ("workforce") and "heroine" ("hero"). This isn't the first time Microsoft is cracking down on language, and it probably won't be the last! Just last year, Microsoft 365 tried to filter swearing and "bad behavior." Microsoft was also ridiculed in November over a video presentation showing senior execs introducing themselves by citing their race and gender pronouns. Marketing manager Nic Fillingham was filmed saying: "I'm a Caucasian man with glasses and a beard. I go by he/him." The Reformed Sage DNB: Founded in 2018, The Reformed Sage exists to edify Christians with products and services that build the kingdom of God and proclaim the gospel to all. We have created products that are unique, useful, beautiful, and humorous. We have wood art, engraved wall art, apparel, drinkware, decals, stamps, and much more. We also regularly make custom merchandise at wholesale prices for churches, ministries and businesses that want to add or expand their product offerings in turn increasing revenue. Please use promo code FLF22 for 10% off your first order. AND HAPPENING NOW: All apparel is marked down until Super Bowl Sunday! (No promo code necessary) Shirts: $20 Hoodies: $30 and more! They are changing apparel vendors and removing some designs. We do not know at this time what color/sizing options we will have available come March 1. So, if there is an apparel combo you want (design/size/color) better grab it before it is gone for good! This sale ends on February 6th. Next up from a listener – and remember you can send stories that you think we should cover on these Daily News Briefs to news@crosspolitic dot com. A Federal Agency Has Begun Collecting Names & Religious Exemption Records https://www.washingtontimes.com/news/2022/jan/11/biden-administration-planning-lists-employees-seek/ The Washington Times reports: An obscure federal agency has proposed creating a database capturing the names and “personal religious information” of government employees who submit “religious accommodation requests” to be exempted from the Biden administration's COVID-19 vaccine mandate. At least seven other federal agencies, including five Cabinet departments, are apparently setting up similar “personal religious information” databases, according to an analyst at the Heritage Foundation, a conservative think tank in the District. The federal Court Services and Offender Supervision Agency for the District of Columbia, or CSOSA, published a “notice of a new system of records” in the Federal Register on Tuesday. The agency, which supervises defendants awaiting trial as well as parolees, aims to “reduce recidivism” and “integrate offenders into the community by connecting them with resources and interventions.” The federal departments of Treasury, the Interior, Housing and Urban Development, Health and Human Services, and Transportation, as well as the General Services Administration and the Securities and Exchange Commission, have each published proposed rule-makings to implement “systems of records” tracking their workers' religious accommodation requests. While there is “some data collection that is likely and legally permissible under Title VII, when an individual at a covered agency requests a religious accommodation,” Sarah Parshall Perry, a legal fellow at the Heritage Foundation's Institute for Constitutional Government, said, “we have not seen it on a broad scale like this ever.” President Biden's COVID-19 vaccine mandate for federal workers took effect Nov. 22 under an executive order he issued Sept. 9. The executive order said its terms were “subject to such exceptions as required by law.” “We're not clear on what personal religious information is going to be gathered” under the CSOSA proposal, Ms. Perry said, adding that numerous sticky questions will come up. “How does one as a federal agency determine the sincerity or lack thereof of an individual's religious beliefs?” she asked rhetorically. “Normally, information like that goes directly to the [Equal Employment Opportunity Commission] and is maintained for internal purposes, just in the case that there is a future dispute about whether or not religious discrimination exists. However, we're not told why or how this information is being used. And that smacks of religious discrimination on a grand scale.” Psalm of the Day: 23 0:20-0:54, 3:33-4:11 The King of Love my shepherd is… Good Shepherd, may I sing thy praise, within thy house forever. Amen. Remember you can always find the links to our news stories and these psalms at crosspolitic dot com – just click on the daily news brief and follow the links. Or find them on our App: just search “Fight Laugh Feast” in your favorite app store and never miss a show. This is Toby Sumpter with Crosspolitic News. A reminder: Support Rowdy Christian media, and share this show or become a Fight Laugh Feast Club Member. What allows us to continuing growing to take on the Big Media Lie Fest is your monthly membership support. If you've already joined, a huge thanks to you, and if you haven't, please consider joining today and have a great weekend.
The Supreme Court on Thursday issued a ruling blocking Biden's vaccine-or-test mandate for large employers but allowed the policy requiring vaccinations for most healthcare workers at facilities that receive Medicaid and Medicare funding to remain in place. The Court ruled 6 to 3 against the Occupational Safety and Health Administration's employer mandate, blocking it from taking effect while other legal challenges play out.
So much about the world remains unknown. What lies in the ocean's depths, the composition of outer space, life after COVID — these are all questions yet to be answered. However, we can discover different solutions for many unresolved problems using critical thinking. We need to stop looking for answers today and look forward; we need to seek the art of the possible. In this episode, Dr Joe Dituri draws from his research and experience to discuss hyperbaric oxygen therapy, space travel, and the right approach to battling COVID. One might think that it takes an advanced academic degree to tackle these concerns and mysteries. However, in the episode, we'll learn that qualifications aren't all there is to it. Finally, he shares how research and studying can unlock doors to a whole world of possibilities. Tune in if you want to learn more about harnessing the art of the possible. Here are three reasons why you should listen to the full episode: Understand more about hyperbaric oxygen therapy and oxygen toxicity. Hear Dr Joe's opinion on how we can solve the current COVID situation — and why the research and doctoral approach just won't cut it. Learn about the importance of diversity of thought and the art of the possible. Get Customised Guidance for Your Genetic Make-Up For our epigenetics health programme, all about optimising your fitness, lifestyle, nutrition and mind performance to your particular genes, go to https://www.lisatamati.com/page/epigenetics-and-health-coaching/. Customised Online Coaching for Runners CUSTOMISED RUN COACHING PLANS — How to Run Faster, Be Stronger, Run Longer Without Burnout & Injuries Have you struggled to fit in training in your busy life? Maybe you don't know where to start, or perhaps you have done a few races but keep having motivation or injury troubles? Do you want to beat last year's time or finish at the front of the pack? Want to run your first 5-km or run a 100-miler? Do you want a holistic programme that is personalised & customised to your ability, goals, and lifestyle? Go to www.runninghotcoaching.com for our online run training coaching. Health Optimisation and Life Coaching Are you struggling with a health issue and need people who look outside the square and are connected to some of the greatest science and health minds in the world? Then reach out to us at support@lisatamati.com. We can jump on a call to see if we are a good fit for you. If you have a big challenge ahead, are dealing with adversity, or want to take your performance to the next level and want to learn how to increase your mental toughness, emotional resilience, foundational health, and more, contact us at support@lisatamati.com. Order My Books My latest book, Relentless, chronicles the inspiring journey about how my mother and I defied the odds after an aneurysm left my mum Isobel with massive brain damage at age 74. The medical professionals told me there was absolutely no hope of any quality of life again. Still, I used every mindset tool, years of research and incredible tenacity to prove them wrong and bring my mother back to full health within three years. Get your copy here: https://shop.lisatamati.com/collections/books/products/relentless. For my other two best-selling books Running Hot and Running to Extremes, chronicling my ultrarunning adventures and expeditions all around the world, go to https://shop.lisatamati.com/collections/books. Lisa's Anti-Ageing and Longevity Supplements NMN: Nicotinamide Mononucleotide, an NAD+ precursor Feel Healthier and Younger* Researchers have found that Nicotinamide Adenine Dinucleotide or NAD+, a master regulator of metabolism and a molecule essential for the functionality of all human cells, is being dramatically decreased over time. What is NMN? NMN Bio offers a cutting edge Vitamin B3 derivative named NMN (beta Nicotinamide Mononucleotide) that can boost the levels of NAD+ in muscle tissue and liver. Take charge of your energy levels, focus, metabolism and overall health so you can live a happy, fulfilling life. Founded by scientists, NMN Bio offers supplements of the highest purity and rigorously tested by an independent, third-party lab. Start your cellular rejuvenation journey today. Support Your Healthy Ageing We offer powerful third-party tested NAD+ boosting supplements so you can start your healthy ageing journey today. Shop now: https://nmnbio.nz/collections/all NMN (beta Nicotinamide Mononucleotide) 250mg | 30 capsules NMN (beta Nicotinamide Mononucleotide) 500mg | 30 capsules 6 Bottles | NMN (beta Nicotinamide Mononucleotide) 250mg | 30 Capsules 6 Bottles | NMN (beta Nicotinamide Mononucleotide) 500mg | 30 Capsules Quality You Can Trust — NMN Our premium range of anti-ageing nutraceuticals (supplements that combine Mother Nature with cutting edge science) combats the effects of aging while designed to boost NAD+ levels. Manufactured in an ISO9001 certified facility. Boost Your NAD+ Levels — Healthy Ageing: Redefined Cellular Health Energy & Focus Bone Density Skin Elasticity DNA Repair Cardiovascular Health Brain Health Metabolic Health My ‘Fierce' Sports Jewellery Collection For my gorgeous and inspiring sports jewellery collection, 'Fierce', go to https://shop.lisatamati.com/collections/lisa-tamati-bespoke-jewellery-collection. Episode Highlights [03:03] Dr Joe's Background Dr Joe did so poorly in his studies that he had no choice but to join the Navy. He has poor vision due to congenital ocular albinism. However, refusing to wear glasses impeded his learning potential. While his mother taught him his work ethic, the Navy taught him discipline. After finding out his learning method, he earned his bachelor's degree in Computer Science and became a Navy Special Operations Officer. [11:22] Becoming a Navy Commander Dr Joe trained to walk on the ocean floor more than swim during his time as a Navy diver. He became a great diver and started writing papers after expanding his diving knowledge. His papers and diving expertise resulted in him receiving a promotion as the officer-in-charge of the Deep Submergence Unit. Upon building a dry combat submersible and bending a few rules, they came up with organisation state rules for the American Bureau of Shipping. [18:25] Life After the Navy After finishing 28 years in the Navy, Dr Joe decided to write a paper on the ketogenic diet. There was a hypothesis that using a ketogenic diet could stave off epileptic seizures on one side. Joe wondered if it would work for hyperbaric oxygen therapy. Then, he decided to pursue a PhD in Biomedical Engineering to write the paper. After writing the paper, Dr Dom D'Agostino invited Joe to work in his laboratory and write a few chapters on a book together. [23:19] Combating Oxygen Toxicity When you're diving, seizure won't kill you; drowning will. Joe's PhD was about designing an early warning detection system for when the autonomic nervous system is stressed. They also redesigned the current spacesuit. [30:36] What Extreme Diving Is Like If there's a leak in your suit at 810 PSI, it would cut you in half and fuse you. With extreme diving, he needed to be calm about his potential death. The fear encouraged more careful measures. Being in charge of the detachment meant Joe carried a significant responsibility on his shoulders. Coming to terms with that responsibility, he devised a robust training plan and surrounded himself with people to help him execute it. [34:58] His Diving Experience They did a scientific expedition on the Britannic to learn why it sank. The black coral dive was the most dangerous dive he's performed. The swinging of the hammer in the water takes so much energy, and it attracts sharks. Your body has compensatory mechanisms that allow you to dive as deep as 2,000 feet underwater. They're looking to break the record by living in an aquatic environment for 100 days. This endeavour also serves as survival training in extreme conditions. Everything we need to survive is on this planet — we just need to look in new places. [48:05] The Art of the Possible We're all just trying to figure out what we're supposed to do. It's not about what is state of the art. Instead, consider the art of the possible. Always keep your eyes ahead. [54:53] The COVID Situation Viruses will kill people. We need a common-sense approach rooted in a combination of politics, medicine, and business rather than just a blanket doctoral approach. Shaming and blaming are fear tactics used during the vaccination period. Rather than pointing fingers, it's more important to find a solution to the problem. [1:00:32] What He's Currently Doing He's working at the Undersea Oxygen Clinic, where they're doing clinical research and a wide variety of treatments. Medicare doesn't hold all the answers; we could refer to the HMO since they have good interests at heart. Tune in to the full episode to find out his studies on post-COVID patients and why sometimes the research itself is the wrong attitude! [1:12:52] Degree vs. Diversity of Thought You can't expect everything to work right away. Degrees and titles mean nothing compared to the ability to think outside the box. The art of the possible requires looking ahead. In the U.S., some legislations grant patients with a terminal diagnosis the right to dictate their own cure. 7 Powerful Quotes ‘There's enough problems that can kill you, and the ocean will happily and gleefully kill you without blinking an eye. It won't even recognise that you're there, so… you actually have to give it a good dose of respect.' ‘... everything that we need on this planet exists on this planet to survive.' 'It's not about the state of the art; it's about the art of the possible. Because the state of the art is yesterday and right now. The art of the possible is way the hell out there.' 'I firmly believe that [the solution to COVID] needs to be rooted not in politics. Not in medicine, but in a combination of politics and medicine and business and acumen.' ‘People will do everything, and then do hyperbarics. Then they go, ‘Hyperbarics didn't work.' Well, yeah, because you waited until the end to try it. If you had done it, it might have helped earlier.' ‘...what degree you have, what title you put before your name, what title you put after your name, it doesn't make a damn bit of difference. If you are a person that can think outside the box, I'd much rather have you in my corner.' 'If you are supposedly at the end of life and have been given a terminal diagnosis and I'm going to die if I do things the way you want to do, then why do you care?' Resources Gain exclusive access and bonuses to Pushing the Limits Podcast by becoming a patron! Learn more about the Undersea Oxygen Clinic. Connect with Dr Joe: Twitter | LinkedIn | Instagram | Website About Dr Joe Dr Joe Dituri is a retired Navy Commander and a consultant for the International Board of Undersea Medicine. He's currently the President of the Undersea Oxygen Clinic and the CEO of the Association for Marine Exploration. He earned his bachelor's degree in Computer Science from the University of South Carolina, a Master's degree in Astronautical Engineering from Naval Post Graduate School, and a PhD in Biomedical Engineering at the University of South Florida. Enlisting in the U.S. Navy in 1985, he was commissioned in Special Operations and became Officer-in-Charge Deep Submergence Unit (DSU) Diving Systems Detachment (DSD). He also won several awards during his service. Joe has written numerous diver-training manuals, co-authored “Tao of Survival Underwater”, contributed to Hyperbaric Medical Practice (4th edition) and the Navy Diving Manual, and has been published in several journals. Currently, he is interested in writing books, skydiving, and being a civilian astronaut. Learn more about Dr Joe's work, including hyperbaric oxygen therapy, on his website. You can also connect with him on Twitter, LinkedIn, and Instagram. Enjoyed This Podcast? If you did, be sure to subscribe and share it with your friends! Post a review and share it! If you enjoyed tuning in, then leave us a review. You can also share this with your family and friends so they can discover the meaning of the art of the possible. Have any questions? You can contact me through email (support@lisatamati.com) or find me on Facebook, Twitter, Instagram and YouTube. For more episode updates, visit my website. You may also tune in on Apple Podcasts. To pushing the limits, Lisa
More than half of Americans are extremely worried about the direction of the country, according to the latest Mood of the Nation poll by the McCourtney Institute for Democracy at Penn State in collaboration with APM Research Lab. We discuss the findings with Eric Plutzer, a political science professor at Penn State and director of polling at the McCourtney Institute. Oil well drilling has picked up in the Permian Basin in Texas, but filling jobs for oil field work has proven to be a challenge. Medicare is challenging the FDA’s approval of Aduhelm, an Alzheimer’s drug.
More than half of Americans are extremely worried about the direction of the country, according to the latest Mood of the Nation poll by the McCourtney Institute for Democracy at Penn State in collaboration with APM Research Lab. We discuss the findings with Eric Plutzer, a political science professor at Penn State and director of polling at the McCourtney Institute. Oil well drilling has picked up in the Permian Basin in Texas, but filling jobs for oil field work has proven to be a challenge. Medicare is challenging the FDA’s approval of Aduhelm, an Alzheimer’s drug.
In our first COVID-response episode of 2022, Senator Turner speaks once again with Dr. Victoria Dooley, a family doctor, social justice activist, and 2020 national surrogate for Senator Bernie Sanders. From COVID variants, to stress on healthcare systems, to universal licensing for physicians, SNT and Dr. Dooley drop important knowledge on how we *will* get through COVID. Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
In this healthcare podcast, I'm talking about direct contracting IRL (in real life) with Katy Talento. This is a conversation that's more about the reality of direct contracting than the theory of direct contracting, and this was not an accident. So much of healthcare transformation is really easy to say and much harder to actually do. So … direct contracting. In the context we discuss in this episode, generally direct contracting means when an employer or their benefits consultant, more likely, hooks up with a provider organization, lots of times a hospital or a health system. Moving forward here, I'm just gonna say employer when I sort of really mean the employer and their TPA and their repricer, the constellation of consultants and other vendors that are working with the employer. So, just for simplicity, the employer says to the provider organization, “Hey, let's cut out the middleman here” (middleman likely being some insurance carrier). “I will just pay you directly, and it will be a win-win because no one is sucking out up to 15% to 20% right out of the middle, and also I'll steer my employees/patients/members your direction, which is great for us as a self-insured plan because money saved and also because I've done some quality analytics and I think you're relatively good at delivering care … so I'm happy to help my members find you.” The employer will, in general broad strokes, pay the provider organization some percentage over the Medicare rate for procedures or codes or bundles. By the way, the dollar amount over Medicare for the bundles or procedures or codes can vary depending on factors like what service line it is because, unlike RBP (reference-based pricing), direct contracting is a negotiation. It's a two-way deal. RBP, a lot of times, is the payer/employer deciding what they're gonna pay and then paying it—without sitting around a table with the provider figuring all this out together. So, if only from this one dimension, direct contracting is something that you'd think that hospitals/health systems/providers would be kind of into and up for. One thing that I didn't really understand before this conversation is that, if we're talking about an employer direct contracting with, say, a hospital, the list of direct-contracted procedures or codes or bundles might include pretty much all of the services that the hospital can perform; but, in general, the employer is only going to steer members there or make it financially attractive to go to the hospital for, for example, emergency or unavoidable procedures. Why? Because no employer wants patients going to the hospital for things that they could get a whole lot cheaper in an outpatient setting with no less quality. So, unless a hospital is willing to compete on price with other care settings, then an employer is not going to steer their members there. If you're a hospital, you might take this as a con. But, on the other hand, consider that if there's a few hospitals in the area, the general direction will be to go to the one with the direct contract. Furthermore, if a plan is gonna steer members, they're gonna steer them whether they have a direct contract with you or not. Katy makes one point early and often throughout this conversation. From a hospital perspective, doing a direct contract is and should be pretty easy. From an employer perspective, too, there should not be a lot of disruption or friction for employees. There doesn't need to be. Done right, it should be a win-win for the employer, provider, and, most of all, the patient who doesn't get stuck with high bills, balance bills, and lower-quality care than might be available to them through their benefits. Katy goes through the steps to create a direct contract and the challenges she has faced along the way. We also get into the wonderful world of payviders, so you could consider this an extension to the episode with Jeb Dunkelberger (EP348) from last month. My guest today, Katy Talento, started out as an infectious disease epidemiologist (which I did not realize). She ended up doing public health policy. She's worked on Capitol Hill for various senators and, in the last administration, as health policy lead. Katy is the CEO of AllBetter Health and works with the Health Rosetta organization. She is a benefits advisor for employers who are looking to create better health plans that reduce costs dramatically while, at the same time, improving benefits. I mean, you can only do that in healthcare, right?—where there's basically no relationship between price and quality. You can learn more at allbetter.health or contact Katy directly at katy@allbetter.health. Katy Talento is an infectious disease epidemiologist, a veteran health policy advisor, and healthcare consultant. She is CEO of AllBetter Health, an insurgent benefits advisory firm building innovative health plans for employers that are free of misaligned financial incentives. Katy served as the health policy lead in the White House on the Domestic Policy Council where her portfolio included public health issues such as eliminating domestic HIV/AIDS, ending secret healthcare prices, lowering prescription drug prices, expanding health IT interoperability, combating the opioids and other drug addiction crisis, and promoting bioethics in the life sciences. Katy has appeared on or been published in a number of media outlets, including CNN, Sky News, Newsmax, The New York Times, The Hill, The Morning Consult, RealClearPolitics, and others. Prior to her White House appointment, Katy served five U.S. Senators over a 15-year period, including as top health advisor and manager of legislative staff and oversight investigators. She also worked in the private sector helping multinational energy companies protect their global workforce from infectious diseases and on the research faculty at Georgetown University Medical School. Katy served as the director of speechwriting for the Republican National Committee and has written a number of published opinion pieces, Web copy, and video scripts. She spent two years as a Catholic nun and has worked with the poorest of the poor from East Africa to industrial Russia and inner-city America. Katy received a master of science degree in infectious disease epidemiology from the Harvard School of Public Health and an undergraduate degree in sociology from the University of Virginia. 05:21 Why are employers direct contracting? 06:37 “When you directly contract … you don't have to chase patients.” 07:43 Why the growing 501(r) movement is making direct contracting more enticing. 10:16 “They're going to be giving better rates, whether they want to or not.” 11:46 “I think it's the future hospitals want, too.” 12:58 What is the primary driver of increased healthcare costs? 14:56 “The fixed costs that the hospitals … have may not be so fixed.” 15:08 “A hospital should not be a freestanding profit center. … The hospital is a failure of healthcare. It alone should not be profitable.” 15:35 “We have the system we have, but why do we have to live with it? We don't have to.” 17:15 What's step 1 of direct contracting? 24:12 What's the TPA's role in direct contracting? 25:21 What's the repricer's role in direct contracting? 33:28 “I think the thing that makes all this work is having a benefits advisor that knows how to do all this.” You can learn more at allbetter.health or contact Katy directly at katy@allbetter.health. @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth Why are employers direct contracting? @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth “When you directly contract … you don't have to chase patients.” @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth Why the growing 501(r) movement is making direct contracting more enticing. @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth “They're going to be giving better rates, whether they want to or not.” @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth “I think it's the future hospitals want, too.” @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth What is the primary driver of increased healthcare costs? @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth “The fixed costs that the hospitals … have may not be so fixed.” @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth “A hospital should not be a freestanding profit center. … The hospital is a failure of healthcare. It alone should not be profitable.” @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth “We have the system we have, but why do we have to live with it? We don't have to.” @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth What's step 1 of direct contracting? @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth What's the TPA's role in direct contracting? @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth What's the repricer's role in direct contracting? @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth “I think the thing that makes all this work is having a benefits advisor that knows how to do all this.” @KatyTalento discusses #directcontracting on our #healthcarepodcast. #healthcare #podcast #hospitals #digitalhealth Recent past interviews: Click a guest's name for their latest RHV episode! Stacey Richter (INBW33), Stacey Richter (INBW32), Dr Steve Schutzer (Encore! EP294), Lisa Trumble, Jeb Dunkelberger, Dr Ian Tong, Mike Schneider, Peter Hayes, Paul Simms, Dr Steven Quimby, Dr David Carmouche (EP343), Christin Deacon, Gary Campbell, Kristin Begley, David Contorno (AEE17), David Contorno (EP339), Nikki King, Olivia Webb, Brandon Weber, Stacey Richter (INBW30), Brian Klepper (AEE16), Brian Klepper (EP335), Sunita Desai, Care Plans vs Real World (EP333), Dr Tony DiGioia, Al Lewis, John Marchica, Joe Connolly
With the start of a new year dampened by Omicron and yet another surge in COVID-19 infections, it's hard not to wonder what this "next normal" will look like for healthcare. After chatting with each of Vynamic's heads of sector, Jen, Mindy & Ryan bring it all together to discuss the trends expected to shape the industry this year. With immense cost strain across the system, plan sponsors are tightening budgets and revising benefit constructs (00:53) and consumers are feeling the squeeze. These costs are often hardest felt amongst those facing socioeconomic inequities – and the pandemic has brought the equity imperative front & center (06:57). The pandemic has also precipitated an innovation explosion – particularly as it relates to everywhere care (12:26) – and it seems data is positioned to become the currency of 21st century healthcare (17:41). A booming senior population with eyes on a new aging (23:25) and the proliferation of transformative therapeutics (27:38) means that industrywide change will be needed, soon.View our 2022 Healthcare Industry Trends infographic at https://vynamic.com/insights/2022-healthcare-industry-trends/. Podcast Tags: healthcare, health plans, providers, life sciences, health tech, health equity, telehealth, digital health, big data, EHR, Medicare, gene therapySource Links:· https://www.beckershospitalreview.com/pharmacy/drug-prices-soared-by-nearly-4-times-the-inflation-rate-in-5-years-house-investigation-finds.html· https://www.fiercehealthcare.com/payer/nationwide-out-pocket-spending-grew-10-to-1-650-per-person-2021-expect-to-continue-through· https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0569· https://med.stanford.edu/dean/healthtrends.html· https://rockhealth.com/aging-in-place/· https://www.thebusinessresearchcompany.com/report/cell-and-gene-therapy-global-market-report-2020-30-covid-19-growth-and-change· https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.01470· https://www.fiercehealthcare.com/tech/majority-healthcare-executives-don-t-trust-their-organization-s-data-survey-finds?oly_enc_id=4902E0496778J3Y· https://www.advisory.com/daily-briefing/2021/11/17/health-equity For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.Mindy McGrath, Healthcare Industry Advisormindy.mcgrath@vynamic.comRyan Hummel, Executive and Head of Provider Sectorryan.hummel@vynamic.comJen Burke, Healthcare Industry Strategistjen.burke@vynamic.com
It's been a year since the #ForceTheVote campaign to pressure progressive Democrats in the House to deny their vote for Speaker from Nancy Pelosi unless she agreed to bring up a Medicare for All vote on the House Floor. Jimmy and comedian Kurt Metzger reflect on what happened to #ForceTheVote. Plus Slate smears Supreme Court members as "anti-vaxx." Also featuring Stef Zamorano!
“What you will gain is so much more than what you will give up.” - Dr. Dean Ornish Dean Ornish, M.D. is highly regarded as “The Father of Lifestyle Medicine,” which is the fastest-growing trend in medicine today, and today's discussion with Rip dives deep into the vast body of work and groundbreaking research that Dr. Ornish has conducted for decades. As the founder and president of the non-profit Preventive Medicine Research Institute (PMRI) for over 40-years, he and his team of researchers have demonstrated time and again how lifestyle medicine can reverse, treat, and prevent chronic disease. How is this possible? Eat Well, Love More, Stress Less, and Move More – all of which are outlined in Dr. Ornish's latest book, “UnDo It - How Simple Lifestyle Changes Can Reverse Most Chronic Diseases,” which has just been released in paperback. From the beginning, Dr. Ornish was met with criticism and skepticism, which would cause even the strongest of physicians to reverse course. But, because of his conviction and the overwhelming data he has produced, the only thing reversing is YOUR chronic disease including heart disease, high blood pressure, diabetes, early-stage prostate cancer, and now – the evidence is showing - even the progression of Alzheimer's. Medicare and many insurance companies are now covering Dr. Ornish's lifestyle medicine program for reversing chronic diseases because it consistently achieves bigger changes in lifestyle, better clinical outcomes, larger cost savings, and greater adherence than have ever been reported—based on 40 years of clinical research published in the leading peer-reviewed medical and scientific journals. Recently, Medicare even agreed to cover Dr. Ornish's program for reversing heart disease when offered virtually via Zoom. Our bodies often have a remarkable capacity to begin healing if we treat the underlying lifestyle factors that cause them—and more quickly than we had once believed. All of this is great news because, as Dr. Ornish stresses, "We don't want take hope away. In fact, we want to give people a sense of hope." He's been giving us hope for over 40 years and, thankfully, he's just getting started. About Dr. Dean Ornish Dean Ornish, M.D., is the founder and president of the nonprofit Preventive Medicine Research Institute, clinical professor of medicine at the UCSF, and the author of seven books, all national bestsellers. He received the Outstanding Young Alumnus Award from the University of Texas, Austin, and the National Public Health Hero Award from the University of California, Berkeley. He was recognized as a “TIME 100 Innovator;” by Life magazine as “one of the 50 most influential members of his generation;” by People magazine as “one of the most interesting people of the year;” and by Forbes magazine as “one of the world's 7 most powerful teachers.” Episode and PLANTSTRONG Resources: Watch the Episode on YouTube Ornish.com Resources Preventive Medicine Research Institute Join us for our 2022 PLANTSTRONG Retreat in Black Mountain, NC - March 1st-6th - Healthcare Providers can earn up to 20 hours of CME credits and 2 CEU credits as part of the registration fee! Jointly provided by UNC Health Sciences at MAHEC - we are thrilled to reward professionals for all they learn at our immersive events. Engine 2 Seven-Day Rescue Book Rip's Rescue with Dr. Brian Asbill - "Make Yourself Heart-Attack Proof" Join the free PLANTSTRONG Community Theme Music for Episode Promo Music: https://youtu.be/rhV_DIoebmU Your Love by Atch SoundCloud: bit.ly/AtchSoundCloud Instagram: www.instagram.com/atchmusic License: Creative Commons License - Attribution 3.0 Unported (CC BY 3.0) Music promoted by Ohzum Beats: https://bit.ly/ohzumbeats
Plus: Kroger shares drop as supermarket workers go on strike in Denver. Biogen shares fall after Medicare puts conditions on Alzheimer's drug coverage. Jefferies earnings miss expectations J.R. Whalen reports. Learn more about your ad choices. Visit megaphone.fm/adchoices
Carl Quintanilla, Jim Cramer and David Faber on inflation watch: Markets rise despite data showing consumer prices up 7% in December from a year ago. Cramer offered his perspective on how Fed Chair Jerome Powell is handling inflation in wake of Tuesday's re-confirmation hearing on Capitol Hill. The anchors also reacted to what Domino's CEO Richard Allison told CNBC about how he sees the inflation picture. Also in focus: The financial sector's record run ahead of big bank earnings, Nasdaq coming off its best day in three weeks: Has it bottomed? Dish Network shares jump on reports it is in merger talks with DirecTV, DoorDash CEO Tony Xu joins the board of Facebook parent Meta and Biogen shares tumble on Medicare decided it would only cover the company's Alzheimer's drug under certain conditions. On day three of the J.P. Morgan Healthcare conference, Meg Tirrell interviewed Novartis CEO Vas Narasimhan about everything from its licensing of a COVID drug to Medicare's decision on covering Biogen's Alzheimer's drug.
Biogen stock falls after Medicare says it will limit coverage for the company's new Alzheimer's drug; the Biden administration says it'll distribute ten million COVID tests to schools each month; Facebook parent Meta drops to the 47th spot in Glassdoor's annual ranking of the 100 best places to work.
Insurance Dudes: Helping Insurance Agency Owners Gain Business Leverage
The World Famous Insurance Dudes chat with JUSTIN BROCKWe Are Insurance Dudes!!! We Are Here To Learn From All The Incredible Insurance Dudes And Dudettes We Speak With And To Pass The Knowledge Nuggets That We Learn To Our Dedicated And Amazing DudeNation!For All Things Related To Being An Insurance Dude or Dudette, Incredible Tips, Amazing Tools, and Valuable Resources Check Out The Insurance Dudes Hub!https://www.theidudes.com/Are you interested in learning “How To Predictably Sell 6-Figures A Month From Insurance Internet Leads While Saving You Time And Money!?"Head over to our free masterclass today! Click Herehttps://www.theidudes.com/masterclass-registration1619461457775..................................................................................................................................................................About JUSTINHe founded the Medicare Gurus Facebook Group which now has over 6,500 members. This group was the first of its kind and has educated and brought agents together nationwide.Justin serves as the Vice President for the Mississippi Association of Health Underwriters (MAHU). Which is the state affiliate of the National Association of Health Underwriters (NAHU). NAHU represents over 100,000 licensed health insurance agents, brokers, consultants, and benefit professionals from across America. Justin is also a contributing member of the Forbes Expert Council on health insurance and Medicare as well as serving as an advisory board member for Manhattan Life Insurance Company.Most notably, Justin is the majority owner and CEO of Safe Harbor Insurance which owns and operates Bobby Brock Insurance and Medicare Gurus.Justin Brock has taken the health & Medicare insurance industry by storm over the last 8 years and has become a pivotal icon that's bringing distant factions of the health insurance market together. He continues to advance the conversation towards the metaphorical “End Zone” by creating digital content and training courses that have elevated the practice of THOUSANDS of health insurance agents across the country.Social Media:Website: Bobby Brock Insurance | Health Insurance Resource Center Website: WWW.MEDICAREGURUSU.COM LinkedIn: Justin Brock - President - Bobby Brock Insurance | LinkedIn Facebook: Bobby Brock Insurance | Facebook Instagram: Оксана Синягина (@bobbybrockinsurance) • Instagram photos and videosYouTube: Justin Brock - YouTube
The Biden administration plans to offer schools free rapid Covid-19 tests. Medicare officials propose covering the cost of the new Alzheimer's disease drug Aduhelm for certain patients. Keith Collins hosts. Learn more about your ad choices. Visit megaphone.fm/adchoices
If you're lucky enough to find an at-home COVID test, private insurers will soon be required to pay for it. Medicare decides to only cover Biogen's controversial Alzheimer's drug for a subset of patients in clinical trials. And Omicron is forcing millions to call out sick.
As David explains, there are two ways of controlling our budget: raising revenue or reducing spending (or some combination of the two), just like an American household. Rebecca Walser thinks that Modern Monetary Theory (MMT) could be decimated by Covid-19. And there are a few key issues that have surfaced: the U.S. Government printing $8 trillion and the equity market going up over 40% (pre-Covid) with no economic fundamentals to support it, 10 million job openings, supply chain issues, as well as interest rates that are outrageous and inflation way too high year over year. Rebecca defines MMT as the theory that states that ‘we can print money indefinitely and to perpetuity as long as we can service the debt.' However, MMT sort of requires that you don't believe in inflation any longer, for the fact that if MMT is true, then inflation will never occur. For Rebecca, the law of economics is just too big and too right to bow to the theory of MMT. As a result of that, we have a hard inflation that, despite manipulation by the U.S. Government by taking out food and energy, still leads to massive price increases year over year – increases that are not transitory. As Rebecca shares, from a perspective of tax law, life insurance is the only asset class that can have both tax-free income, a tax-free estate, and that can still be accessed during our lifetime. It's a combination of four different tax law provisions, no other asset class that has so many tax provisions specifically arranged around it. After seeing the impact of Corona – and the $8 trillion being spent – Rebecca has given up on rates normalizing over the next 20 years. She sees life insurance as the planning tool that can be leveraged from both an estate tax perspective, and what she refers to as a ‘parallel wealth track'. The retirement of baby boomers represents the largest demographic shift in the history of America. 65 million more people coming out of the workforce and going on to social security and Medicare will lead the U.S. to have their back against the wall. According to Rebecca, the retirement of baby boomers is something that has been anticipated since the ‘70s but nothing has been done about it. As a result of this phenomenon, she predicts America will transition to a European taxation model. Rebecca doesn't consider herself a huge fan of leveraging income annuities, because she sees it as the equivalent of taking a pile of cash and creating a lifetime income stream. There's an exception to this last point, though: if Rebecca has a client she feels is going to really struggle to maintain their income for the rest of their life, then that is a perfect use for that particular vehicle. To Rebecca, it appears that people don't seem to realize that financial asset classes change over time. The downside is what makes retirees run out of money and it's something people don't plan for. However, it's a key factor because, as Rebecca explained, as long as you avoid the downside you “win the battle” – even if you planned on a mediocre 4% return for the rest of your life. As she shared, people are so used to chasing returns that they don't understand that there's a peak, a point in life at which a person moves from accumulation to distribution. Distribution rules are different from accumulation rules. There's a dilemma many of us face: how do we give our children something more than we had, without quenching their innate desire to make something for themselves because they have been challenged? This is one of the reasons why, in Rebecca's opinion, you see so many wealthy people's children going the wrong way - becoming addicted to a substance, etc. – because they just don't have an outlet for their individual need to become something.
This week, Dexcom CEO Kevin Sayer spoke to the JP Morgan Healthcare Conference about the G7 and beyond. We talk about information from that presentation and get to as many of your questions as time allows. This interview took place on Tuesday Jan 11 and much of what we discussed isn't FDA approved. Dexcom presentation info here Club1921 info here Our usual disclaimer: Dexcom is a sponsor of this podcast, but they don't dictate content and they don't tell me what to ask their executives. Recent Dexcom episodes: CTO Jake Leach talks about Garmin, Dexcom One & more CEO Kevin Sayer talks about G7, Direct to Watch, Adhesive and more CEO Kevin Sayer talks about Dexcom in Hospital, G7, VA program and more Check out Stacey's book: The World's Worst Diabetes Mom! Join the Diabetes Connections Facebook Group! Sign up for our newsletter here ----- Use this link to get one free download and one free month of Audible, available to Diabetes Connections listeners! ----- Episode Transcription Below Stacey Simms 0:00 Diabetes Connections is brought to you by Dexcom. Take control of your diabetes and live life to the fullest with Dexcom and by Club 1921. Where Diabetes Connections are made This is Diabetes Connections with Stacey Simms. Welcome to another week of the show. You know I'm always so glad to have you here. We aim to educate and inspire about diabetes with a focus on people who use insulin. And I'm talking with Dexcom CEO this week, it's Kevin Sayer, he is back to check in with us again. And in the interest of getting this episode out to you as soon as I could. It might sound a little different right here at the beginning. But Dexcom episodes are always so high interest that it really merits a quick turnaround. I didn't want to sit on this interview for a week. So here's the setup. Dexcom CEO Kevin Sayer gave a presentation to the JP Morgan healthcare conference, if you're listening as this episode goes live, that was just Monday of this week, January 10, the interview you're about to hear took place on Tuesday, January 11. My usual disclaimer Dexcom is a sponsor of this podcast, but they don't dictate content and they don't tell me what to ask their executives. I asked the Diabetes Connections podcast Facebook group for questions. And Whoa, boy, did you have a lot as always not a surprise. And I really appreciate you sending those in, I got to as many as I could, while also trying to include what the folks at Dexcom had really asked me to bring up there are some topics that they wanted Kevin to make sure to address. And I think we do a pretty good job of trying to reach a balance here. Kevin, welcome and Happy New Year, Kevin Sayer 1:46 and Happy New Year to you. Stacey Simms 1:48 Thank you. Well, this seems to have started out in pretty happy way on the headline, just from this week. Dexcom CEO touts unprecedented performance of G7 in clinical trial. This is after your talk at the annual JP Morgan healthcare conference. Tell me a little bit about that unprecedented performance data. Kevin Sayer 2:08 I'm happy to. And I just have to qualify it by saying no, I can't send it to all your listeners at the end of the call yet. We're still waiting for approval in Europe. And we have filed this with the FDA, I'm going to take you back a little bit, we made a decision when we were going through the G7 development process that we wanted to answer that performed better than G6. And all of our scientists looked at us and they go oh, really, you're sure because this is really good. And so we spent a lot of time new algorithms and new manufacturing techniques, there's a lot of things in G7 that make it different. We also wanted to validate that performance with a study that was so large, nobody could refute it. So as you look at the data that I presented at the conference yesterday, over 300 patients 39,000 Match pairs all across since one ranges and on the I CGM standard side, but with the 5% 95% lower bound, and even the absolute points, you can see we are well within all of the iCGM standards, which are very technical and actually are a very good measure of how a sensor actually performs in reality. And they were very thoughtful in developing these standards to try and pick the centers that don't work to put you statistically in a bind to whereby if you really aren't performing in the low range or wherever, you're not going to get that iCGM designation. We're very comfortably there. And the overall MARD in the study, Stacey is eight point, you know I it's in the low eight for adults and pediatrics. And if you start looking at the data, we gather the data sets in three periods, you know, days one and two, the middle days, four, or five and six, and the last days nine and 10. It's pretty low, I think it's below 10. In the first group a day, the first days, which are always a little bit higher, traditionally in our centers than the other days. But in those middle and end days, it's it's near seven, and strips for six. I mean, we have done something that I've been in this business for since 1994. I didn't think we'd ever do this when I started. As far as being this good. This is really, really good data. And we're going to continue to deliver the experience to our customers that they demand from us. So as you can as you think about an iCGM that's driving an automated insulin delivery system. And not only is the performance great, the user where it's 60% smaller, it's a 30 minute warm up. It's a new app. From our perspective, we've got a lot of the clarity data, your listeners will know about clarity. We've got a lot of your clarity data right on the app. There's new alarm configurations. Stacey Simms 4:48 I'm gonna just jump in with a couple of quick clarifications before we go on. You mentioned a number of there that went by quickly I apologize when you talked about the 300 people in this trial 39,000 match what I missed that one Kevin Sayer 5:00 matched pairs. That's where you compare the CGM value to the blood glucose value from the laboratory instrument. So the way our studies work is literally we draw blood samples from the individuals in the study at intervals, and then we actually match the CGM data to that laboratory blood instrument. So 39,000 points from these 300 people in this study were matched. Got it? Stacey Simms 5:27 And you mentioned the MARD mean absolute relative difference. Most of you, as you listen are very familiar with this, the lower the better for CGM G6, I, my understanding was G6 was in the low nines. This is 8.1 for peds. 8.2 for adults, as I'm reading it, that's right. I know you can't tell me I'll ask you anyway, why? What made the difference here? Is it sighs is it algorithm? Do you have anything you can point to? Or is that a trade secret Kevin Sayer 5:49 it's combination, I think the algorithm has been the most, the algorithm changes were really extensive here. And, you know, we always have manufacturing processes to get better, the way we build the G7 centers different in every step of the way. Literally, our G6 manufacturing processes go away and the G7 ones take over the summer, we're a little similar on the actual sensor wire itself, and that manufacturing, but everything else is different. We just think it it's smaller, it's a lot shorter than G6 was. And so it is it's going to be a completely different experience for everybody. Stacey Simms 6:28 So to go back to what you were talking about, before I jumped in there, you were starting to talk about alarms, is there something different for the alarm, Kevin Sayer 6:35 the app is different. And so access to them, and, and just how you use them, if we try to get to be more consumer, thoughtful, as we configured the alarms, we'll see how everybody loves him. It'll be interesting. The alarms are one of the things we get the most comments on when we launch a product initially, we try and please everyone, but we never please everyone. And then you get you know, the agency at one time. I don't know if your call. I think one of our other discussions, we had to make the mute override not work on the low end. Boy, we got a lot of people mad at us about that one. So we've tried to comply with what our users want, and also comply with what the FDA has asked us to do. But I think users will find the alarm experience. Good as well. I like I think it's just gonna be a home run. Yeah, well, I Stacey Simms 7:24 mean, my son would be happy if an alarm never made a noise again. And I know other people who put like it to alarm every time there's any movement. So I hear where you're coming from, can you give any insight into the G7 app in terms of what the differences that we may see as users? And I guess especially one of the questions I always get is about follow any changes of significance coming that you can share follows Kevin Sayer 7:47 on a separate software track. And so the G7 system, the app is just we tried to get more data in the app itself, versus what we have with G6. So a lot of the clarity data, or at least summary query data is sitting there right in your app. And that will be i we think people will like that just to see how they're doing over time you got your time in range data for, you know, three 714, you know, a month, 90 days, see how you're doing time in range wise and the app is other than that it's relatively similar. The startup is different and you know, in the interface is going to be different. I think over time, what you'll see with us is that app is now going to get more sophisticated, we changed the entire software platform for G7 and started over again, and we developed a software platform, we can now really change and add on to a lot easier than we could in the past. And so we're hoping to have more frequent software releases. But we've also learned that CGM is not like Battlestar Galactica game, a game where you want to get a new release every two weeks to fire everybody up. We can't do a release every two weeks, because people depend on this for their, you know, for their lives. And if you do too frequent releases, and you botch a release, you do some wrong, you remember what happened, if we ever make a mistake on the software, the data side, we can't do that. But we do want to add more features more quickly in this platform will enable us to do that. I think one of the things you'll see going forward on the software side, we really want to automate a lot of the tech support features. We've added some, you know, you can get FAQs right from the app now with respect to your sensor, but there are other things we think we can do tech support wise in the app that will you know, reduce everybody's burden. Nobody likes making a phone call and nobody likes picking up the phone. And when we have a sensor fail, and we do have sensors fail, it just doesn't make any sense that you have to call us if we've got data on a phone, it'd be much easier. For example, if we could diagnose that failure right on the app and go through a very quick process to why but where you could get one. I can't give a timeframe when all those things are going to come but the platform is robust enough that over time, we can add features like that. One of the other nice things about G7, since it's fully disposable, you know, every sensor has its own unique serial number. Whereas with G6, that same transmitters used with three months' worth of sensors. So it will be, it will be fun to be able to follow things like that and see how the sensors go through the channel where everybody gets attract things of that nature. So what we're really looking forward to the change in our business that G7 affords us. Stacey Simms 10:28 As usual, I have listener questions, I'm going to try to not repeat because you've been really accessible in the last year, we've talked to a couple of folks from Dexcom, besides yourself. So as you listen, if I didn't get to your question, or if you have a question, good chance, we actually answered it in the last year, year and a half. But given let me ask you about compression lows, because that's one of the things we had talked about, about testing the G7. Any update on that in these trials, if you lay on it, you know, circulation slows, and you can get a false reading any better with the G7 Kevin Sayer 10:54 part of the clinical study is in the compression, because you're pretty much sitting in a chair with a needle in your arm drawing blood. So I'm sorry, we can't really test that we'll learn more about compression when it gets in the field. My hope is that it isn't as much but I can't promise that because I don't know, we're not enough people. I think there are ways over time where we can manage compression better, I'm not going to get into all the science on the phone, believe it or not, I do spend a lot of time with the engineers on this specific issue. Because I have it happened to me from time to time too. So I will call them up say Hey, can we do X, Y or Z? And I think there are some some answers, but I can't give them away because I don't want to give away the playbook. So let's let's just see what we can do overtime on that one. Stacey Simms 11:42 Okay. All right. But you know, the next clinical trial just have them lean against the side of their bed. Kevin Sayer 11:46 We will we'll have to do well. Diffic very scientific. Stacey Simms 11:50 Another question came up, and I think I'm gonna knock wood. I think we've been very lucky on this. It's about new iOS launches from Apple. And I'll read the question and it'll tell you, briefly our experience. This person said Dexcom is part of the Apple Developer Network developers have access to new release such as iOS months before launch, why does Dexcom lag behind Apple iOS launches by months in terms of quote, approved use. And our experience, frankly, is that we have not had any issues Benny and I both have, we just got but as a 13. Plus, we both had very old phones. And we have a latest software and no glitches for us. But that's not everyone's experience, can you talk a little bit about that, Kevin Sayer 12:30 we do get the iOS versions in advance, and we do our best to comply with them, I would I would tell you that it isn't as simple as it's made out to be. And the iOS version that's launched isn't always exactly what we've worked on as they as they make tweaks, not big ones. But you also test for everything that you know about the new iOS versions, and sometimes are things that you don't know, that are in there that come back and may affect the app later on, which is why we delay a little bit, we try and go through every bit of testing that you can imagine. And I'll be honest with your users, Apple's made iOS changes, because of us, we have called up and said, Look, you got to do XY and Z here we have a problem. And they're very good to work with, they've not been difficult at all, you know, when you think about iOS and Android operating system and all the things that they impact. And it's very hard not to impact somebody adversely when you do a new iOS launch. And you know, the perfect example with us is the home you'd override journey that I brought up earlier. In the beginning, I believe the only app that can overcome the mute override within iOS is authorized manna in the beginning was Apple's alarm clock, but other people would go around it with their apps was a medical device, we can't do a go around, we have to make sure what we do is in compliance and known so they work with us very well to make sure we could do what the FDA wanted with respect to the mute button. And the same thing with Android on that, and that was a very difficult exercise. So if there's a delay, it's because we're taking time to see what might have been put into iOS that would change our app. And it just one more thing that will stop. new operating systems are often designed to minimize power usage to extend battery life. Oftentimes, minimizing power usage affects an app that has to be running continuously. And those are the types of battles that we fight are things that we have to make sure we test as a new iOS minimizes power usage. Just does that turn us off? Does it does that stop Dexcom? And we've had, we've discovered things of that nature where it could affect our app. So there you go. Long answers. All right. Stacey Simms 14:44 No, no, that's great. And you mentioned you've asked iOS you've asked Apple to make changes. I assume the alarm was one any others that you can share. Kevin Sayer 14:52 I know that nothing I could share. Nothing major that I like you said they're very cognizant of the Dexcom community there we are. You know, we're we're a very large part of the iOS, you know, we're pretty, it's pretty vocal group when it comes to iOS, Stacey Simms 15:06 pretty vocal group period, the whole community. Alright, we say that with love. So another question came from my group, which was about Sugarmate. This is a, I would describe it as a third party app that uses the Dexcom information. And now the real time API to display and and act on data in its own way, my understanding is that Tandem owns Sugarmate, just from way of background here. And you know, Dexcom owns a little bit of Tandem. So there's a relationship there. Can you speak a little bit about data sources, but the bottom line question here was using Sugarmate and the situation to ask you, does Dexcom feel like they own the patient data? Or do the patients still own their data, even when going through the Dexcom web API's, we believe Kevin Sayer 15:49 the patient's own their data, not us, let me rephrase that we believe the patient's control the use of their data, we are the stewards of that data sitting on our servers. And so we have a responsibility to maintain it and to keep it but where that data goes and where that data is used. We do believe, particularly if it's identified data, that the patient absolutely has complete control over that there's vector sugar made, it's interesting, it was not using API's before it was a like many and non authorized use of the data to display it in a different format that people quite candidly, mess, like better than looking at the Dexcom app. And that's fine. That's why we built the live API's, we made a server change to upgrade our server platform, again, more capacity, more safety, more redundancy. It's a project that's been going on for years. And we've come to the end of that project this year. And when doing so there were some technical issues with Sugarmate, they very quickly switched over to the live API's. And now this is an authorized use of the data based on platform and data pipes that we built. So we're willing to share the data with people when they want it. I think that's an attitude of Dexcom. That changed very much over the years, when we first started, we had a hard time with that concept. Because we worked so hard to invent this technology and gather this data, why would we share it with anybody and say, See, you remember the early days and Nightscout, they were mad at us, we were mad at that. Now, we're not mad at anybody anymore. I think it's important that the data sharing be structured and be used for good purposes. But you know, all in all, it's a, it's a good use of the data that we have, because these are still Dexcom customers. If you want to, you're still buying sensors and using them. It's not a bad thing. Stacey Simms 17:35 Let me ask you a question about the sensors. And this came up in the fall. I've seen it less since but it's still out there. And I don't know if this is something you can answer. But it seems that we have not received this. But it seems that some customers are getting the G6 sensors, the inserters brand new in the original packaging, but a new label on it that says this product meets shelf-life extension requirements. I'm your people I reached out to them in the fall, they told me the stickers, oh, you know, it's all legit. There are updated expiration dates. But I'm curious why this is happening. And you know, what is the shelf life of the G6, Kevin Sayer 18:10 I can tell you exactly what's going on, you do shelf-life testing for product as selling your product will last. And over the course of our product lifecycle, you trying to extend that shelf life through more testing to make sure the product still works for the same amount of time period, if you manufactured product with 12 months shelf life, and then extend that shelf life to 18 months. And it's still the same product and still same manufacturing process rather than unbox it, put it in a new box or throw it away, we put a sticker on the outside because it's same products been tested, it's been proven that it works for 18 months, that's not a problem. That doesn't mean that it's 18 months old, we never have inventory that sits around that long to my knowledge, but we do extend shelf lives, it's important for us to do that, with respect to the distribution channel, particularly as we go to the pharmacy, you know, in the drugstore and and our distributors, the longer they have, you know that they can keep product, the better. We don't want people throwing product away if they don't have to. So all that means is we've extended our testing and shown that the product still works for a longer period of time and wanted to to label the product accordingly. That's all Stacey Simms 19:17 Yeah, I think because it came at a time when there is nervousness just in general not just in diabetes about supply chain and, you know, scarcity concerns. It just seemed unexpected, if that makes sense. Kevin Sayer 19:30 Well I one of the reasons to extend life is in fact supply chain we don't have inventory issues with G6 you know G6 is a very very well running process right now and still, you know, the premier sensor on the market. In fact, we launched a G6 derivation product in Europe, these past three months called Dexcom. One a it's a cash pay product sold on the E commerce platform in four European countries say See now and it's a lower price and geographies. But we did a feature that we took away, share and follow. We're not connecting any devices. It's it's a simpler technology. And again, we have d six supply to be able to go and do things like that. And we are planning to have G7 capacity to do similar things. We are not shooting small on either front will have capacity on both sides. And, you know, listeners on a supply chain perspective, we have been extremely diligent with respect to components for our products. And right now we see things very good today. We my operations team has just been outstanding on this front. So knock on wood, no, no Dexcom problems today. Stacey Simms 20:40 All right, two more questions for you. As always, we're going to run out of time. And as you're listening, I would refer you again, we did have a conversation about Dexcom. One in a previous show. So I will link that up. This one is more of I've asked this, you answered it, but I still continue to get questions to please ask you please make sure when GS seven comes out that Medicare is taken care of? Kevin Sayer 21:00 Well, that is a great question. And I think we've learned from our mistakes in the past. So we will when we get G7 done, what we will do is we will file with CMS to get G7 reimbursement. That's a process that I've heard anecdotally takes three to six months. So if we can get it done in three months, we can't file with CMS until it's approved. But we'll file after approval, and then we'll go and it is our plans to have capacity for all of our US users. When we go it is not that Medicare delay for G6 was one of the most emotionally gut-wrenching things I've dealt with here, because you can't imagine how many emails I got. But we didn't have capacity, and we didn't have everything ready. We've learned from our mistakes. And we'll hopefully be ready to go to everybody. That's our plan right now. Stacey Simms 21:49 That's great. Okay, and my last question is, and I hate doing this to you, but I'm doing it anyways, look into the chapter, we're gonna look, we're gonna come at it sideways, because I did have one listeners and ask him what's planned for the g8? And I said, Come on, let's let him get the G7. Oh, you know what? I'm happy? You can answer that. Let's go for it? Kevin Sayer 22:07 Well, well, I'll give you two because we did lose some time in the beginning because my computer wasn't functioning properly. As we look to the future, we want performance to continue to be better. And then we ask ourselves, but we're getting to the point where as you get to an eight, Mar D, we're getting close to finger six, I don't know how much more of a gap there's going to be, as we look to the future, and even G7 derivatives, we want to go to a longer life, we want to go to 15 days rather than 10. We'll be running studies doing that over the next couple of years. We've got a couple of plans there. We're always looking to upgrade the electronics, and how much better electronics, you know, I know one of your bigger user complaints is connectivity and loss of data, how do we improve that experience for our customers to make that better over time? Because we can always be better. And phones change faster than medical devices? So what why do we put there, we're looking at ways how we can help the environment for future product launches again, and changes in the next platforms, G6 has a lot more materials than G7 does as far as just raw plastic. So how do we make an impact there? On the cost side, there's some form factor things that are pretty far out there that we look at that I won't go into that are really, really fun. We'll see if we had done that. And if they're feasible from a cost of manufacturing perspective, but again, we're now very much focused on customer preference, rather than can't we make this work well enough, you know, in my early days here, it's Can we can we just get this thing working well enough to whereby people can rely on it. Whereas now it's one of those features that are going to make it a more engaging experience. And the last one will be software and analytics and things like that, as I look out over time, do we end up with analytics to whereby we can offer our users a menu of choices on the software side to whereby they can get more if you want Dexcom when don't want to connect or talk to anybody? You can have that if you want something that literally literally analyzes every glucose measurement that you take and does something scientifically. How do you get there, I think there's a number of experiences we can develop over time for future product generations without changing the form factor. So I don't see any slowdown in investment on the r&d side. And on the product side, G6 is the best product out there now and G7 will just be better in every way. And then we just keep going from there. Stacey Simms 24:27 And I appreciate you answering that. Thank you. So if you keep going from there, this is the sideways kind of question I wanted to ask. Okay, go ahead. Okay. A couple of days ago, Abbott announced the idea of what they're calling Lingo, which is bio wearables that will track not only glucose, but ketones and lactate and alcohol. And they say these are not medical devices. You know, this is for people who want to be you know, ultra-marathoners and things like that. We're already seeing sensors used in that way right now. Any plans to do something like this? Kevin Sayer 24:56 You know what our electronics platform for G7 We could put any, if we could develop a sensor wire with membranes and analytes and such for to measure something else, it would fit right into G7. And we design G7. With that in mind, we have advanced technology work going on with the other analytes. But it's still an advanced technology phase, we have to answer a couple of questions. First, have we done all we're supposed to do on the glucose side? Before we run there, and we got a lot to do right now, Stacy, you've heard me talk on this call. And so we need to get done what we started, we need to get G7 launched, we need to scale it up and manufacture it in the 10s. And ultimately, hundreds of millions of products as we stand up a factory in Malaysia and get our Arizona facility built out even more. So we've got to get that work done. The second piece, I'm going to answer this in three pieces. The second piece is what is the commercial opportunity for each of those things. They did announce this line of sensors, but they're all individual sensors. So I've worn a lactate sensor, I'll be completely honest with you from the lab and seeing what it does to my workouts and it's very cool, I can see which workout is better than another one. But I'm not ultra-marathoner, I probably wouldn't change my life. But it was very interesting to look at. There are other scientific uses of black data, particularly in a hospital setting. But what is the market for those, and so we're gonna kind of take an approach, we'll continue to develop the science and if Abbott wants to go develop a market, I am happy to follow this time rather than create it, like we've done with glucose. The third piece of this is there are a lot of biosensors out there. Now, you have your Apple Watch, and Apple is continuing to gather more and more data or ranks, whoop bands, Fitbits, they're advertised on television all the time, I would love to incorporate data from these other sensing technologies into into Dexcom. And vice versa, share our data with those people, particularly as you head down the health and wellness path. And let's get some other people's sensors into our platform. In all honesty, if Abbott's really good at sensing these other things, we'll take that data on our platform and analyze it to if they want to, I guarantee you, that probably isn't gonna, gonna happen. But we would, you know, let's be open about this. We're going to get our glucose work done to because we've not seen an opportunity that exceeds this. Stacey Simms 27:13 Got it? Excellent. Well, thank you so much for answering that it really is so interesting to watch and to see if, as you say, if any of this really, really makes a difference commercially, if people do want to adopt it widely. You know, I think the jury's still out, so we shall follow. Kevin Sayer 27:26 Hey, thanks for having me again. Stacey Simms 27:27 Thank you so much. Have a great day. You're listening to Diabetes Connections with Stacey Simms. More information at the episode homepage, diabetes, Dash connections.com. I'll have the transcription up as soon as I can. But again, quick turnaround on this episode. Thank you so much, again, for sending in the questions. Obviously, I didn't get to all of them. And if you're not in the Facebook group, that's generally where I asked for questions for this kind of thing. It's Diabetes Connections of the group. I'll link it up in the show notes. As always, I know not everybody's on Facebook, please feel free to always email me if you email me now about Dexcom. I'll save those questions until the next time we talk to them. It's Stacey at diabetes connections.com. Again, it's in the show notes and it's on the website. But I get it not everybody is on Facebook these days. To that point, at the very beginning of the show, in that little sponsor tease before things even begin, I mentioned club 1921. So let me tell you a little bit more might be an update for some of you. Maybe some of you are hearing about this for the very first time. Briefly, club 1921 is a website. It's a project I've been working on for a long time. And it is a place where anyone with any type of diabetes can find events anywhere in the United States. We are in beta right now. I invite you to go to the website club 1920 one.com. Until around, check it out. Let me know what you think we've immediately identified we went into beta, late last fall several things mostly about the signup that need to be fixed, those could be fixed by the time you log in, my guess is closer to the end of January. There's a little bit of confusion there. I'll explain in a moment. But other than that, it's pretty well set. The idea here is that instead of a Google Calendar or something like that, this would be a website where you go, you sign up, you tell us what kind of events you're looking for, and then you never have to come back, we'll email you automatically. When events that meet your criteria are edit, very easy. So you pick your type of diabetes, you pick your location, you pick which type of events you want, you pick your age, I mean, you can just say I want everything in every category you can kind of go through, but whatever you pick, and you can change those if you want to come back and change your filters, but whatever you pick, we will email you when those events are added. If you want to add events. There are two types of events you can add one we're very creatively calling events. This is your JDRF walk. This is your friends for life conference. This is your hospital education for people with type two. It's an event by an organization a was a staff an event where they expect lots of people or it's regularly scheduled, or there's a fee, that kind of thing. The other kind of events we're calling Hangouts. These are my favorite types of events. I love what we're calling Hangouts. This is your mom, coffee, your kid play date at a playground, you know, you're going out to a bar, post COVID, with your adult friends with type one, hang outs are not put on by an established organization. They're put on by people like you and me, we don't have a staff, we just want to meet people in our area. When you're adding those. That's where a lot of the confusion came up in the registration process. Because if you want to add events or Hangouts, you actually have to sign up in a different way. So I'm going to talk more about that as the weeks go on. We're fixing that part of the website. But if you try to sign up and you see some confusion, it may be because you are trying to add an event or a Hangout. If you want to just sign up to learn about the events and Hangouts, it should be pretty simple. But if it's not, if you have any questions, any suggestions, please let me know. Email me Stacey at diabetes connections.com. Pretty soon you'll email me Stacey at Club 1920 one.com You're going to be hearing a lot more about this because I'm so excited about it. Yes, I know, we might not have a lot of events this year, that's fine. We're going to have events, eventually, in the diabetes space. Again, we're gonna have lots of events, and social media, Facebook, even things like Eventbrite are a terrible way to get the word out about them. And it shouldn't be work to find them, you should be able to just raise your hand and say, I want to know about this stuff. And it should automatically come to you. And that's what I'm hoping to do here. Okay, back to our regular schedule with the podcast. We will have our Wednesday in the news that's live at 430. Eastern on Wednesday on YouTube and Facebook, and then 445 on Instagram. And then that turns into an audio podcast episode for Fridays. And hopefully next week, we're back to Tuesday and Friday. And we won't do any of this nonsense of pushing episodes around. But I do appreciate your patience. Again, I didn't want you to wait a week for this interview. All right, thank you as always to my editor, the very flexible and understanding John Bukenas from audio editing solutions. And thank you so much for listening. I'm Stacey Simms. I'll see you back here in just a couple of days until then, be kind to yourself. Diabetes Connections is a production of Stacey Simms media. All rights reserved. All wrongs avenged
To support this ministry financially, visit: https://www.oneplace.com/donate/1085/29 They say you should always be nice to your kids because one day they'll choose your nursing home. Okay, it's an old joke, but there's some truth in it! However, one way to keep more decision-making power in your hands is to have long-term care insurance. We'll explain today on MoneyWise. COST OF LONG TERM CARE If you don't have long-term care insurance or a huge pile of money, you'll be limited to nursing facilities that accept Medicaid. Most of them do, but they're not necessarily the best. Now, you're probably thinking, But long term care insurance is so expensive. And it does seem that way until you look at assisted living care costs: on average about $275 a day. That's more than $8,000 a month! Premiums vary widely. They depend on your age, health status, and the area where you live. According to the American Association for Long Term Care Insurance, the average policy will cost around $2,500 a year for a couple at age 55. That figure jumps almost $1,000 a year if the same couple purchases a policy at age 60. And it only goes up from there, so that age range, 55 to 60, is probably the best time to purchase a long term care policy. WHAT DOES LONG-TERM CARE INSURANCE COVER? Long-term care insurance covers your expenses if an illness, disability or impairment prevents you from performing everyday activities, including bathing, dressing, eating, and walking. If you can't do those things on your own, you can't earn a livable salary or care for yourself. And the older you are, the more expensive long term care insurance becomes. Here's what long-term care insurance isn't: It's NOT health insurance. It won't cover the treatment of an illness to improve your health. It just pays for the care needed to maintain the quality and routine of your daily life. So long-term care insurance is a supplement, designed to cover what health insurance, Medicare or Medicaid might not cover. It doesn't replace health insurance. But that doesn't mean you're not getting a lot of bang for your buck. Long-term care insurance covers a long list of important services, starting with adult day care facilities. These are activity centers for seniors that provide a certain amount of supervision with a minimal level of care. They might have social workers and medical personnel on staff. It will also pay for home care services that help with things like cooking, cleaning and bathing. It also covers assisted living facilities for people who need help with daily activities but don't require nursing. Respite care is also covered. This provides family caregivers with intermittent breaks so they can maintain their own lives. It might include home-based care, adult day care, and short term institutional care. Then, of course, there's nursing home care that provides help with everyday functions and medical care. A long-term care policy may also cover stays in specialized nursing homes that provide care for diseases like Alzheimer's. But no matter what kind of care you might need, insurers know it's cheaper to pay for it if you're able to stay in your own home. So policies will cover home modification costs for things like remodeling bathrooms for wheelchair accessibility. And of course, long term care insurance will typically pay for hospice care when a policyholder is nearing the end of life. WHO SHOULD BUY IT? Should everyone get long-term care insurance? It's not for everyone, but it does make sense for most people eventually. Generally, If you've accumulated enough wealth to pay for long term care without seriously depleting those assets, you don't need it. But you're in a very small group. And if you have very little in assets, you probably can't afford it. If you're in the middle, where the vast majority of us are, then you do need it. Without long term care insurance, you could easily burn through your life savings if you ever need an extended stay in one type of facility or another. But some of you may be thinking, I don't need long term care insurance because Medicaid will cover that care for free if I go into a nursing home. Ah, not exactly. Medicaid is designed to cover long term care for low-income people only, and that means you'll have to use up most of your assets paying for care before Medicaid kicks in. So, not really free at all. Then, of course, some people try to hide their assets and still qualify for Medicaid. But this is dishonest and Christians shouldn't do it. Proverbs 3:27 reads, Do not withhold good from those to whom it is due, when it is in your power to do it. Well, I hope all of this has convinced you to start thinking seriously about getting long term care insurance especially at age 55 and beyond. LISTENER QUESTIONS On today's program, Rob also answers listener questions: ●Does it make sense to move up your timeline for buying a home with rental prices significantly elevated? ●Are pre-paid funeral arrangements worthwhile? ●How do you make beneficiary and end-of-life decisions if one of your adult children is making poor lifestyle choices? ●When does it make sense to refinance your mortgage? Remember, you can call in to ask your questions most days at (800) 525-7000 or email them toQuestions@MoneyWise.org. Also, visit our website atMoneyWise.orgwhere you can connect with a MoneyWise Coach, join the MoneyWise Community, and even download the free MoneyWise app. Like and Follow us on Facebook atMoneyWise Mediafor videos and the very latest discussion!Remember that it's your prayerful and financial support that keeps MoneyWise on the air. Help us continue this outreach by clicking theDonate tab on our websiteor in our app.
Should you use your personal name as a beneficiary of a Lady Bird Deed or should you set up a new entity to receive ownership? In the first Tax Tuesday episode of 2022, Toby Mathis and Jeff Webb of Anderson Advisors discuss how to set up a beneficiary deed and answer additional tax-related questions. Submit your tax question to taxtuesday@andersonadvisors. Highlights/Topics: Are the profits from my real estate syndication investment considered passive income? It's highly likely that your syndication income is passive in nature for two reasons - you're probably a limited partner and it's real estate, which are both passive activities. Should I use my personal name as a beneficiary of a Lady Bird Deed or should I set up a new entity to receive ownership? Medicare can take a real estate asset to pay for care, but a Lady Bird Deed is an enhanced life estate allowed in five states for a beneficiary to protect their home as an inheritance. How does a C Corp pay me (the homeowner) for the use of part of my house as office space? Don't report it on your 1040. It's a tax-free reimbursement. However, if you rent your home to the corporation, then it is taxable income. Can we still rollover a regular IRA to Roth? For now, you can still do a Roth conversion. For all questions/answers discussed, sign up to be a Platinum member to view the replay! Go to iTunes to leave a review of the Tax Tuesday podcast. Resources: Lady Bird Deed https://www.medicaidplanningassistance.org/lady-bird-deeds/ Business Structures https://www.irs.gov/businesses/small-businesses-self-employed/business-structures Coronavirus Aid, Relief, and Economic Security (CARES) Act https://www.congress.gov/116/bills/hr748/BILLS-116hr748enr.pdf Retirement Plans https://andersonadvisors.com/retirement-plan/ Toby Mathis https://andersonadvisors.com/tobymathis-2/ Anderson Advisors https://andersonadvisors.com/ Anderson Advisors Events https://andersonadvisors.com/all-events/ Anderson Advisors on YouTube https://www.youtube.com/channel/UCX5nh607M8hSBLiMB9MgbIQ Anderson Advisors on Facebook https://www.facebook.com/AndersonBusinessAdvisors/ Anderson Advisors Podcast https://andersonadvisors.com/podcast/
After Biogen halved the price of its Alzheimers drug Medicare reevaluates its Part B premium hike. Omicron's deluge on hospitals could be even worse than what's being reported. And six former White House COVID advisors call for a new covid strategy.
Every work has paid into or is currently still paying Social Security and Medicare taxes. We all hope to see those benefits come our way someday. In this episode, we discuss the current state of these programs, how this may impact you in the future, and what you can begin to do about it.
"Let us hope that this is a one in a hundred years pandemic. We don't want to build our health care system to operate at all times as if tomorrow will be COVID." - Sherry GliedOn December 15, Health Affairs published ahead-of-print, “National Health Care Spending In 2020: Growth Driven By Federal Spending In Response To The COVID-19 Pandemic,” the annual national health expenditures article prepared by the Centers for Medicare and Medicaid Services (CMS) Office of the Actuary. Always one of Health Affairs' most-read articles, this year's provides the first official report on spending that reflects the effects of COVID-19. During a live Lunch and Learn event, a discussion was held on the findings with economists Sherry Glied from the Robert F. Wagner Graduate School of Public Service at New York University and Craig Garthwaite from Northwestern University's Kellogg School of Management. The event was held on January 5, 2022.Listen to Health Affairs Senior Editor Laura Tollen interview Sherry Glied and Craig Garthwaite about what's behind the numbers regarding the latest national health care spending report, long COVID, health care spending reform, which hospitals gained the most during the pandemic, delayed care, and more. Lunch and Learn events hosts top researchers and analysts on timely topics and initiatives impacting health policy. Interested in attending future events? Sign up for Health Affairs Today or Health Affairs Sunday Update newsletters to be the first to hear about the upcoming events. If you enjoy this interview, order the January 2022 Health Affairs issue.Pre-order the February 2022 Racism and Health issue.Subscribe: RSS | Apple Podcasts | Spotify | Stitcher | Google Podcasts
Insurance Dudes: Helping Insurance Agency Owners Gain Business Leverage
The World Famous Insurance Dudes chat with JUSTIN BROCKWe Are Insurance Dudes!!! We Are Here To Learn From All The Incredible Insurance Dudes And Dudettes We Speak With And To Pass The Knowledge Nuggets That We Learn To Our Dedicated And Amazing DudeNation!For All Things Related To Being An Insurance Dude or Dudette, Incredible Tips, Amazing Tools, and Valuable Resources Check Out The Insurance Dudes Hub!https://www.theidudes.com/Are you interested in learning “How To Predictably Sell 6-Figures A Month From Insurance Internet Leads While Saving You Time And Money!?"Head over to our free masterclass today! Click Herehttps://www.theidudes.com/masterclass-registration1619461457775..................................................................................................................................................................About JUSTINHe founded the Medicare Gurus Facebook Group which now has over 6,500 members. This group was the first of its kind and has educated and brought agents together nationwide.Justin serves as the Vice President for the Mississippi Association of Health Underwriters (MAHU). Which is the state affiliate of the National Association of Health Underwriters (NAHU). NAHU represents over 100,000 licensed health insurance agents, brokers, consultants, and benefit professionals from across America. Justin is also a contributing member of the Forbes Expert Council on health insurance and Medicare as well as serving as an advisory board member for Manhattan Life Insurance Company.Most notably, Justin is the majority owner and CEO of Safe Harbor Insurance which owns and operates Bobby Brock Insurance and Medicare Gurus.Justin Brock has taken the health & Medicare insurance industry by storm over the last 8 years and has become a pivotal icon that's bringing distant factions of the health insurance market together. He continues to advance the conversation towards the metaphorical “End Zone” by creating digital content and training courses that have elevated the practice of THOUSANDS of health insurance agents across the country.Social Media:Website: Bobby Brock Insurance | Health Insurance Resource Center Website: WWW.MEDICAREGURUSU.COM LinkedIn: Justin Brock - President - Bobby Brock Insurance | LinkedIn Facebook: Bobby Brock Insurance | Facebook Instagram: Оксана Синягина (@bobbybrockinsurance) • Instagram photos and videosYouTube: Justin Brock - YouTube
My guest today is a skilled developer and asset manager with extensive experience in full gut renovation projects, new construction, and commercial development. She owns a rental portfolio comprised of long- and short-term rentals and is the go-to person when it comes to implementing processes that allow for scalability. Andresa Guidelli is the co-founder and CEO of The Real Estate InvestHER community, co-host of The Real Estate InvestHER Show, and co-author of “The Only Women in the Room: Knowledge and Inspiration from 20 Women Real Estate Investors”. Today Andresa shares her early sales experience and how the techniques she learned help seed her entry into real estate investing and her first 15 rehab projects. You'll learn how she leverages her time, skill set, and funding in order to grow her portfolio to include larger multifamily and apartments. Andressa also shares what its like to be a woman real estate investor and the misperceptions she's had to confront. She'll share the common hurdles women face, as well as the assets they bring to the table. I know you're going to enjoy this conversation with Andresa. You can find out more about her at https://www.therealestateinvesther.com Today's episode is brought to you by Green Property Management, now offering a $250 per unit project allowance to new clients in West Michigan. Text "Green250" to 21000, or visit them at https://www.livegreenlocal.com/. And RCB & Associates, helping Michigan-based real estate investors and small business owners navigate the complex world of health insurance and Medicare benefits. Visit https://www.rcbassociatesllc.com/ to learn more.
Lee Camp looks at how the capitalist system sits at the heart of the worst problems facing society. In this history lesson, Camp takes you back to the feudal system, to the creation of corporations and currency, to the modern system that's destroying the lives of the poor today. The ruling class don't even try to hide the inhumanity that keeps the system running anymore, now that it has become almost impossible to ignore. This leaves it up to popular movements to end the capitalist system and create something new. Then, Camp reports on the police brutality victims who don't gain as much attention as those murdered by cops, and Marilyn Manson's #MeToo allegations. Afghanistan's economy is suffering under US sanctions after the 20-year war on the Afghan people. To try and fix the situation, Joe Biden has made an attempt to create exemptions to the sanctions to encourage trade but the business community isn't biting. So the people of Afghanistan are being punished again for a terrorist attack that they didn't pull off. Finally, Anders Lee exposes the plot to privatize Medicare… because our for-profit healthcare system is working so well for the rest of us.
This episode provides an in-depth analysis of Friday's Supreme Court hearings on the Biden administration's contested COVID-19 regulations set separately by OSHA (Occupational Safety and Health Administration) Emergency Temporary Standard covering employers with 100 or more employees and CMS (Centers for Medicare & Medicaid Services ) Emergency Regulation covering healthcare workers.
The -Round-Up- program is back from its holiday break. Here's a brief list of news stories noted by Jim- ----The Supreme Court heard oral arguments this morning concerning OSHA's mandate on businesses of 100 or more as well the mandate on hospitals and their workers that would be recipients of either Medicaid or Medicare funding.----Hyperbole and overreach are two words that came to mind when thinking about how Democrats talked about the January 6, 2021, -insurrection-.----VP Kamala Harris compared the Capitol breach of January 6th, 2021, to the attack on Pearl Harbor and to 9-11.----During an interview in May of 2020, Dr. Anthony Fauci began to refer to Chinese Commu..., only to backtrack and call them -...scientists.- Was this a Freudian slip- ----President Biden maintained that COVID-19 is an illness of those who refuse the vaccine, stating that those who have not received shots should be alarmed by the highly transmissible Omicron variant even as it rampages through the unvaccinated population.----The phrase -fully vaccinated- is being replaced by -keeping your vaccinations up to date- according to Dr. Anthony Fauci.----Mayo Clinic confirms they've fired some 700 employees that would not comply with their policy to get vaccinated against COVID-19 by Monday.----A federal judge issued a preliminary injunction on Monday stopping the Department of Defense and the Biden Administration from punishing U.S. Navy Seals who objected to getting COVID vaccines on the grounds of religion.
Evangelical worship in the House of Representatives … and more on today's CrossPolitic Daily News Brief. This is Toby Sumpter. Today is Friday, January 7, 2022. Yesterday, Nancy Pelosi led the House of Representatives in a worship service: 6:19-6:33, There was a prayer to some unnamed deity: 8:23-8:29 A homily: 9:14-9:33 Concluding with a moment of silence: 13:49-13:55 And at some point there was a praise song: 3:08-3:45 So pretty much it was exactly like most evangelical worship services in this country. You are the light of the world, and what the church does, the world follows suit. We've been worshiping idols, and so our nation worships idols. We say Lord, Lord, Lord, Lord, Lord, and we don't know who the Hell we're talking about. And so, neither do our leaders. We sing stupid songs to our idols in our church services, and so Nancy Pelosi leads the House Democrats in singing stupid songs to their idols. Supreme Court to Hear Case for Federal VAX Mandate https://www.wsj.com/articles/supreme-court-to-weigh-vaccine-requirements-for-the-workplace-11641481822?mod=hp_lead_pos5 From the WSJ: The Supreme Court will hold a special session today to consider whether the Biden administration can enforce vaccine-and-testing rules for large private employers and a vaccine mandate for most healthcare workers. The issues come to the court on an emergency basis during a record increase in U.S. Covid-19 infections. In a departure from its usual procedures, the court is hearing arguments on cases that haven't been fully aired in lower courts. Technically, the justices—all of whom, according to a court spokeswoman, are fully vaccinated and have received booster shots—don't have to issue a definitive decision on whether the administration's vaccine rules are lawful. Instead, they are considering whether President Biden's team can implement them now while more detailed litigation continues. The cases, however, will require the justices to assess whether the White House has credible claims that it stayed within legal boundaries as it has sought to use longstanding laws to implement aggressive rules in the name of public health. The answer is likely to decide the fate of the administration's current approach to a virus that has killed more than 800,000 Americans and infected more than 50 million. Moreover, the court's decisions could reset the public-health playbook for years to come. The Supreme Court's conservative majority is skeptical of broad claims of federal power and has been considering arguments for reining it in, said Michael Greenberger, a law professor and director of the Center for Health and Homeland Security at the University of Maryland. But with the vaccine cases, the justices “are walking into the jaws of the pandemic,” he said. “And there may be enough justices who would worry that pulling back [the mandates] in the middle of the pandemic is a dangerous thing to do.” Mr. Biden in September introduced several interrelated mandates on vaccination against Covid-19. The private-employer and healthcare rules, both formally issued in November, are coming before the justices while other requirements, including vaccination mandates for federal workers and contractors who do business with the federal government, remain in lower courts. The regulations for large employers, issued by the Occupational Safety and Health Administration, require businesses with 100 or more employees to ensure that their workers are vaccinated or tested each week for Covid-19. The policy covers some 84 million workers. The administration intended the rules to go into effect in early January, but because of legal uncertainties, OSHA recently said it would give employers until Feb. 9 before fully enforcing them. One federal appeals court blocked the rules nationwide in November, but another court reinstated the requirements last month. The vaccination mandate for healthcare workers comes from the Centers for Medicare and Medicaid Services, which said facilities that accept money from those programs must comply. The mandate covers more than 10 million healthcare workers. Lower courts have blocked that mandate in half of the states, but the agency is preparing to begin implementing it this month in states where it is allowed to do so. A Little History Lesson Long ago, the Supreme Court upheld the power of state governments to mandate vaccinations. In the 1905 case, Jacobson v. Massachusetts, the justices upheld the state's authority to require that individuals vaccinate against smallpox. “The liberty secured by the Constitution…does not import an absolute right in each person to be, at all times and in all circumstances, wholly freed from restraint,” Justice John Marshall Harlan wrote for the court. In 1922, the court upheld the city of San Antonio's power to require proof of vaccination to enroll in public school. During the coronavirus pandemic, the justices already have turned down several challenges to orders from state officials requiring that healthcare workers and returning college students obtain vaccines. The current legal challenges to the Biden administration's vaccine rules covering employers and healthcare facilities are based less on their substance than their source: the executive branch of the federal government. The challengers argue that Congress never granted the power for such mandates to the secretaries of labor and of health and human services. For support, they look to the Supreme Court's decisions last year that terminated a moratorium on evictions ordered by the Centers for Disease Control and Prevention, on the grounds that the ban exceeded the agency's authority. The Supreme Court is considering emergency requests by 26 business groups and 27 states to block the vaccine-and-testing rules for private employers. The business litigants, including trade associations representing retailers, wholesalers and transportation and energy companies, said Covid-19 vaccines “are undeniable marvels of modern medicine” that companies have promoted to their workforces. “But the reality is that tens of millions of Americans remain unpersuaded,” they said in court papers. Companies, they said, will either have to absorb testing costs and pass them along to consumers, or make unvaccinated workers responsible, “who will quit en masse rather than suffer additional testing costs each week.” A Kaiser Family Foundation survey in November found that 49% of employees in relevant workplaces in November opposed the federal vaccine-or-testing mandate and 49% supported it. A far higher proportion of Democrats and vaccinated employees backed the measure. The business groups and the states, nearly all led by Republican attorneys general, argue that Congress never clearly gave OSHA the power to conscript businesses into implementing a vaccine-and-testing mandate. They also say the agency unlawfully adopted the mandate without first formally seeking input from the public. The states separately argue that if OSHA's mandate is permissible under federal workplace-safety law, then the regulations raise constitutional problems, because public health-and-safety initiatives are powers reserved for the states, not the federal government. In response, the Justice Department, representing the administration, said OSHA has a clear grant of authority from Congress to ensure that all workers have safe and healthy working conditions. And the vaccine-and-testing rules raise no constitutional problems, the department said, because the federal government has the power to regulate businesses that participate in interstate commerce. Blocking the OSHA rules “would cost many worker lives and result in thousands of worker hospitalizations—all the more so as the pandemic's most recent surge drives case counts to new highs,” U.S. Solicitor General Elizabeth Prelogar wrote in court papers. It was the Biden administration that filed the emergency appeals to the Supreme Court in the healthcare cases after it lost some lower-court rulings to state attorneys general who sued to challenge that mandate. There, the administration argues that it has the power to ensure that Medicare and Medicaid providers meet the needed health and safety standards to protect patients. And it said the government has clear authority to impose conditions—including vaccine requirements—on facilities that accept federal healthcare funds. The states challenging the policy say it will exacerbate an already critical shortage of healthcare workers, particularly in rural communities. There is no set timetable for the Supreme Court to issue its decisions, but given the time-sensitive nature of the disputes, rulings are likely in a matter of weeks, if not days. While you're waiting for that decision, have you subscribed to the Fight Laugh Magazine. I'm holding the brand new Christmas Issue in my hands. Fight Laugh Feast Magazine DNB Our Fight Laugh Feast Magazine is a quarterly issue that packs a punch like a 21 year Balvenie, no ice. We don't water down our theology, why would we water down our scotch? Order a yearly subscription for yourself and then send a couple yearly subscriptions to your friends who have been drinking luke-warm evangelical cool-aid. Every quarter we promise quality food for the soul, wine for the heart, and some Red Bull for turning over tables. Our magazine will include cultural commentary, a Psalm of the quarter, recipes for feasting, laughter sprinkled through out the glossy pages, and more. Seattle-Area Prosecutor Slammed for Mocking Rehabilitation Legislation https://www.foxnews.com/us/seattle-area-prosecutor-juvenile-restorative-justice-program-guns-school A Seattle-area prosecutor was slammed over a recent presentation to law enforcement officials in which he insisted police should "get used to" the district attorney's office allowing juvenile suspects – even those accused of bringing a gun to school – to avoid jail time. Ben Carr, senior deputy prosecuting attorney for King County, made a recent Zoom presentation on "considerations for juvenile suspects." "Even for serious offenses the primary focus will be on rehabilitation," Carr wrote, adding in parentheses, "get used to this concept." The prosecutor presented a scenario where "young Timmy brings a pistol to school, brandishes it during a confrontation and causes panic," before debating whether a crime was committed, whether the juvenile court has jurisdiction in this case and what will happen to the kid "in Juvie." That slide in particular drew ire from officials in the Seattle suburb of Federal Way, which has seen at least six instances over the past year of guns confiscated at schools in its district. According to the presentation, if a student enters juvenile court, the case will result in "most likely, no time in custody and no ultimate conviction." Carr then presented on a "new concept of diversion," after King County Council recently approved a "restorative community pathways" program for juveniles. Juveniles or adults charged with a first-time "non-violent felony offense" may be offered an opportunity to skirt appearing before a judge and instead face a "non-profit community panel" to decide how they "can be held accountable for their crime." Carr was forced to explain to his boss why the slideshow featured a popular meme of a dog sipping coffee in a burning building. "This is fine," the dog says ironically, surrounded by flames. KTTH said those groups that submitted the program proposal are run by liberal activists, many of whom have advocated for either abolishing or defunding the Seattle Police Department. According to Carr's presentation, juveniles accused of assault, burglary, criminal trespassing, felony harassment, obstructing a law enforcement officer or second-degree unlawful possession of a firearm can still be referred to the restorative justice program and avoid appearing before a judge. Now as best as I can tell, this is a great example of Right and Left feeding right into one another's narratives and ruts. Like an old argumentative couple, the Left and Right in this narrative actually need each other and feed off one another's hypocrisies. It's a little convoluted, but it looks like a Righty mocked a Lefty proposal for Rehabilitation for juvenile delinquents. Rightys think Leftys go soft on crime. And that's because they do. And they do because they have rejected Original Sin, and they think people do bad things because they didn't have enough chocolate milk when they were little or maybe they had too much chocolate milk, I can't remember. But the Rightys have their own problems. They want to be tough on crime, but that isn't the same thing as being biblical about crime. The Leftys right that incarceration doesn't solve problems. In fact, there's virtually no place for imprisonment in biblical law. Basically, you have two options for crimes: restitution or the death penalty. If it can be paid back or restored in some fashion, then pay back what you stole, what you damaged, plus double or more depending on how egregious the crime was. And if you took a life, then your life is forfeit. No mass incarceration. And so when it comes to non-violent juvenile delinquents, I'm in the odd position of agreeing with the Leftys while not trusting them to do any good with their rehabilitation classes and maybe even making the delinquents more violent. Because man, what makes a person more frustrated that having to listen to liberals preach about morals they know nothing about. And remember there are a bunch of kids were talking about here whose fathers have abandoned them. Men and churches need to step and step in. So what we need is a Psalm. Psalm of the Day: 10 0:00-0:55 You are the helper of the fatherless. Amen. Remember you can always find the links to our news stories and these psalms at crosspolitic dot com – just click on the daily news brief and follow the links. This is Toby Sumpter with Crosspolitic News. A reminder: Support Rowdy Christian media, and share this show or become a Fight Laugh Feast Club Member. Remember if you didn't make it to the Fight Laugh Feast Conferences, club members have access to all the talks from Douglas Wilson, Joe Boot, Jeff Durbin, Glenn Sunshine, Nate Wilson, David Bahnsen, Voddie Baucham, Ben Merkle, and many more. Join today and have a great day.
On January 7 the Supreme Court will hear oral argument in a set of cases challenging the Biden administration's Covid vaccine mandates. Under one mandate, employers with more than 100 employees must require those employees to be vaccinated, or be tested for Covid on a weekly basis. Under the other mandate, any health care facility that participates in Medicare or Medicaid must ensure that all their workers are fully vaccinated. Joining host Jeffrey Rosen are two attorneys who filed amicus briefs in these cases. John Masslon, senior litigation counsel at Washington Legal Foundation, filed an amicus brief arguing against the legality of the mandates, and Deepak Gupta, founding principal of Gupta Wessler and instructor at Harvard's Supreme Court Litigation Clinic, filed an amicus brief in support of the legality of the mandates on behalf of the American Public Health Association. The National Constitution Center relies on support from listeners like you to provide nonpartisan constitutional education to Americans of all ages. In honor of the 234th anniversary of the ratification of the U.S. Constitution, every dollar you give to support the We the People podcast campaign will be doubled with a generous 1:1 match up to a total of $234,000, made possible by the John Templeton Foundation! Visit www.constitutioncenter.org/we-the-people to donate, and thank you for your crucial support. Questions or comments about the show? Email us at podcast@constitutioncenter.org. Continue today's conversation on Facebook and Twitter using @ConstitutionCtr. Sign up to receive Constitution Weekly, our email roundup of constitutional news and debate, at bit.ly/constitutionweekly.
On January 7 the Supreme Court will hear oral argument in a set of cases challenging the Biden administration's Covid vaccine mandates. Under one mandate, employers with more than 100 employees must require those employees to be vaccinated, or be tested for Covid on a weekly basis. Under the other mandate, any health care facility that participates in Medicare or Medicaid must ensure that all their workers are fully vaccinated. Joining host Jeffrey Rosen are two attorneys who filed amicus briefs in these cases. John Masslon, senior litigation counsel at Washington Legal Foundation, filed an amicus brief arguing against the legality of the mandates, and Deepak Gupta, founding principal of Gupta Wessler and instructor at Harvard's Supreme Court Litigation Clinic, filed an amicus brief in support of the legality of the mandates on behalf of the American Public Health Association. The National Constitution Center relies on support from listeners like you to provide nonpartisan constitutional education to Americans of all ages. In honor of the 234th anniversary of the ratification of the U.S. Constitution, every dollar you give to support the We the People podcast campaign will be doubled with a generous 1:1 match up to a total of $234,000, made possible by the John Templeton Foundation! Visit www.constitutioncenter.org/we-the-people to donate, and thank you for your crucial support. Questions or comments about the show? Email us at podcast@constitutioncenter.org. Continue today's conversation on Facebook and Twitter using @ConstitutionCtr. Sign up to receive Constitution Weekly, our email roundup of constitutional news and debate, at bit.ly/constitutionweekly.
Senator Turner talks music and Medicare for All with Portland's Peter Marks, founder of Rhythm Nation, a member-driven non-profit organization created to build power for working people with a passion for music. Having met on the Bernie Sanders campaign trail, these two break down Peter's personal reason for why he fights for better drug pricing -- for all. #HelloSomebody Learn more about your ad-choices at https://www.iheartpodcastnetwork.com
In this episode of the Darshan Talks Podcast, host Darshan Kulkarni Pharm.D, MS, Esq. discuss 340B Pharmacy Programs with guest Rita Baskett. Rita Baskett RPh, MBA/MHA, CEO of Integrated Pharmacy Services, Inc. that is a consulting firm that concentrates on 340B solutions. The company focus on the integration of compliant pharmacy solutions to improve costs and health outcomes through the use of government programs (when applicable and qualified) and technology partners. 340B is a part of statute written in 1992 with the federal registrar that requires drug manufacturers to provide outpatient drugs to eligible health care organizations and covered entities at significantly reduced prices. The 340B Program enables covered entities to stretch scarce federal resources as far as possible, reaching more eligible patients and providing more comprehensive services. The hospital started using 340B for retail prescriptions and later it morphed into mix used areas including emergency room, observation status, etc. There are certain hospitals that qualify and one of the criteria is it has to be non-profit, the drugs are intended for outpatient use. The second criterion requires that the hospital have a sufficient Medicare disproportionate share hospital (DSH) adjustment percentage. DSH hospitals must have an adjustment percentage greater than 11.75 percent for the most recent cost reporting period ending before the calendar quarter involved. Sole community hospitals and Rural referral centers must have an adjustment percentage of greater than 8 percent. Connect with Rita Baskett: On LinkedIn: https://www.linkedin.com/in/rita-bask... Email : rita.baskett@ipsconsultants.com Website: ipsconsults.com Connect with us: Website: http://www.darshantalks.com Law Firm: http://www.kulkarnilawfirm.com Twitter: https://twitter.com/darshantalks LinkedIn: https://www.linkedin.com/in/darshanku... ---- Disclaimers: 1. This discussion is merely an oral discussion and should not be relied upon solely on its own to support any conclusion of law or fact. 2. The discussion does not and should not reflect any individual products status as safe, efficacious, adulterated, or misbranded or meeting or not meeting expectations at a local, state, federal, or international agency or organization. 3. The discussion should not be construed to be complete advice that is right for you and may not necessarily represent a specific product. 4. This discussion is provided for general educational purposes and should not be construed as legal advice, regulatory advice, or medical advice. 5. This does not create an attorney-client relationship #pharma #340B #darshantalks #hospital #federal Learn more about your ad choices. Visit megaphone.fm/adchoices
© 2020-2022 Ivy Podcast Discovery LLC
